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1I.
INTRODUCTION
1.0 General Introduction to Metal-Nanoparticles 
The idea of manipulating materials at the nanoscale was first laid out in 1959 by the physicist 
Richard Feynman.1 However, due to lack of advanced instrumentation, it  took many decades to 
put this idea to practical use. The last 20 years have seen the advent of sophisticated instruments 
that are able to investigate and manipulate matter at the nanoscale. This has greatly enhanced the 
understanding of the nanoscale world.
Nanoparticles are generally regarded as materials which have at least one dimension falling 
within the nanoscale range (1-100 nm in diameter).2a-e At this nanoscale level the ratio between 
the surface and inner atoms become significant. Hence the quantum effects and surface atoms 
with partial coordination strongly influence the physical, biological and chemical properties of 
these nanoparticles. These unique properties that are dependent on the size and shape of the 
nanoparticle greatly differ from the bulk material.2a-e
In the last two decades, there has been a rapid increase in research especially  on noble metal 
nanoparticles of different size, shape and stability for multiple applications: imaging, catalysis, 
electronics and the development of antimicrobial coatings.2a-e Among the noble metals, gold and 
silver nanoparticles have gained enormous interest  for their multiple applications. The fields of 
application of such noble metal nanoparticles include photography, catalysis, biological labeling 
and bioactivity, optoelectronics and surface-enhanced Raman scattering (SERS) detection.2e
Metal nanoparticles display surface plasmon resonance (SPR) absorption bands in the UV-Visible 
region.2a-e For Cu-, Ag- and AuNPs the plasmon frequencies occur in the visible region making it 
easier to control nanoparticles, for example in the case of their use as bioimaging agents.2 In 
addition SPR allows better monitoring of nanoparticles during their application like in bio-
2imaging.3 Surface Plasmon Resonance arises when the metal nanoparticle which has a size 
smaller than the wavelength of light interact with the oscillating electromagnetic field of light. 
The energy  from the incident electromagnetic field, forces electrons in the conduction band of 
atoms to move back and forth with respect to the nanoparticle positive lattice (plasmon 
oscillations) (Figure 1). At a characteristic frequency the movement is most intense and the 
process resonant (surface plasmon resonance).2c This frequency depends on the nature of the 
metal and the nanoparticle size, shape, chemical surrounding, adsorbed species on the surface and 
dielectric constant.
 
Figure 1: Schematic representation of surface plasmon (electron cloud) oscillation under the 
effect of an electromagnetic field
Silver nanoparticles (AgNPs) have great properties such as high extinction coefficients, sharp 
extinction bands, high ratio of scattering to extinction and excellent field enhancement.2 Similar 
to other noble metal nanoparticles like gold or platinum nanoparticles, AgNPs possess very high 
surface to volume ratio.2e Since their first synthesis, AgNPs have found their way into many 
different areas of science where the properties of AgNPs are utilized.4 
1.1 Application of Silver Nanoparticles
This section highlights some of the most recent applications of AgNPs such as in catalysis, 
antimicrobial agents, cancer therapy and electronics.
31.1.1 Silver Nanoparticles as Catalysts
AgNPs possess a very  high surface to volume ratio, which is crucial for applications as catalysts.2 
Porco et al. used silica-supported AgNPs as solid and recyclable catalysts for the Diels-Alder 
cycloadditions of 2′-hydroxychalcones and dienes in high yield and turnover number.5
Scheme 1: Generalized mechanism for AgNP-catalysed cycloadditions 2′-hydroxychalcones and 
dienes5 
The synthetic challenges involved in this reaction are that the dienophile, 2′-hydroxychalcone 1 
shows poor reactivity and it resists traditional Lewis acid promoted conditions.5 Such a behaviour 
could be due to its electron-rich nature and the tendency of undesired cyclisations to form 
flavanones. Furthermore, the requisite diene 2 has been found to undergo olefin isomerization 
and polymerization under acidic conditions which complicates chemical synthesis efforts.5 
However, in the presence of AgNPs which may serve as catalysts by  acting as electron reservoirs 
and shuttle electrons to the reaction site through high selective activation of 2′-hydroxychalcones 
for cyclo-additions (Scheme 1).5
4The versatility of AgNPs as catalysts is also shown in many catalytic reactions which have been 
published.6-9 For example Yan et al. applied AgNPs in the catalysis of the three-component 
coupling reaction of aldehyde, alkyne and amine with good to excellent yields in one reaction 
vessel thus saving time and materials (Scheme 2).6 
Scheme 2: AgNP-catalysed three-component coupling reaction of aldehyde, alkyne and amine6
In order to address the problem of AgNP contamination by undesired products during the 
reduction of nitro groups, Shin et al. supported AgNPs on Fe2O3 (Scheme 3).7 By choosing the 
reduction of 4-nitrophenol as a reaction model, the authors reported that AgNPs supported on 
Fe2O3 could be separated from the product, 4-aminophenol after the AgNPs catalysed the 
reduction process. Furthermore, the catalyst could be successfully  recycled and reused in 21 
successive reactions with conversions of 100% within 3 min periods. 
  
Scheme 3: Schematic representation of the performance of Fe2O3@AgNPs as catalysts in the 
reduction of 4-nitrophenol to 4-aminophenol by NaBH47 
In another study Liu et al. reported the use of AgNPs in the catalytic oxidation of CO.8  In 
addition, Hamal et al. published the photo-degradation of gaseous acetaldehyde catalysed by 
AgNPs.9
51.1.2 Silver Nanoparticles as Antibacterial Agents
The current upsurge in research on AgNPs for antibacterial applications is prompted by the rapid 
increase in microorganisms’ resistance to conventional chemical agents.10a,b At the same time as 
the old antibiotics are losing their effectiveness, the supply of new drugs is declining. Only two 
completely new classes of antibiotics have been introduced over the past 30 years.10b The new 
classes of antibiotics approved in the last 30 years are the oxazolidinone linezolid (Zyvox, Pfizer) 
and the lipopeptide daptomycin (Cubicin, Cubist Pharmaceuticals) approved in 2000 and 2003 
respectively (Figure 2).10b        
 
  a)         b)
Figure 2: Two completely  new classes of antibiotics oxazolidinone linezolid (a) and lipopeptide 
daptomycin (b) approved over the past 30 years10b
This poses an urgent and important need for an alternative and efficient way  to combat microbial 
infection before it gets out of control. One approach has been the resurgence of ionic silver 
containing drugs such as silver sulfadiazine and Elastoplast® Silver HealingTM  bandages for use 
as antibiotics which have been previously  used for decades.11a,b Unfortunately, such drugs have 
limited application as antimicrobial agents since they become easily  inactivated upon reaction 
with bio-fluids.12 In addition, the salts of silver interfere negatively with antimicrobial activity  of 
these drugs. Recent studies indicate that many of these limitations can be overcome by using 
silver nanoparticles (AgNPs) which even show enhanced antimicrobial activity over ionic silver.
11a,b The exact mechanism of how AgNPs out-perform Ag+-salts in the antibacterial action is still 
6yet to be explored. The properties of AgNPs can be manipulated to fit dimensions which enable 
the nanoparticles to pass through biological membranes and affect cell physiology which has 
been a challenge for the conventional chemical antimicrobial agents.11b The dimensions of 
AgNPs play a major role in their antimicrobial activity and studies showed smaller nanoparticles 
to have greater antimicrobial effect than larger ones.11 
Samsung’s washing machines and refrigerators are some of the earliest consumer products where 
AgNPs were incorporated to kill bacteria and to prevent biofilm formation. Samsung claims that 
the washing machine achieves 99.9% sterilization and kills about 650 different types of bacteria. 
Equally important, Samsung states that the washing machine coats AgNPs onto the fabrics, which 
maintain antibacterial activity for up to a month.13
In another study Elechiguerra et al. demonstrated that AgNPs undergo a size-dependent 
interaction with HIV-1 with sizes of 1-10 nm attaching to the virus surface.14 Due to this 
interaction, AgNPs inhibited the virus from binding to host cells. Figure 3 shows the regular 
spatial arrangement of the attached AgNPs. Silver nanoparticles were speculated to interact with 
HIV-1 virus via preferential binding to the gp120 glycoprotein knobs. This hypothesis was based 
on the center-to-center distance between the AgNPs and the fact that  the exposed sulfur-bearing 
residues of the glycoprotein knobs would be attractive sites for nanoparticle binding.14 
  
Figure 3: High angle annular dark field (HAADF) scanning transmission electron microscope 
image of HIV-1 virus in the presence (a) and absence (b) of silver nanoparticles14
71.1.3 AgNPs in Cancer Therapy
Recently, silver nanoparticles have been reported to have a potential to revolutionize cancer 
therapy.15 Cancer is an important cause of mortality worldwide and the number of people who are 
affected is increasing.16 There are various types of cancer and among them breast cancer is one of 
the major causes of death in women.17 A wide range of drugs such as doxorubicin, cisplatin, and 
bleomycinare are currently used in the treatment of breast cancer however they display 
limitations like health side effects and they  are not as efficient as expected.18 For this reason, it  is 
of great interest to find novel therapeutic agents against cancer. Recent in vitro studies by Franco-
Molina et al. showed anti-tumour activity  of AgNPs through induction of apoptosis in breast 
cancer cells, human breast adenocarcinoma cell line (MCF) without  affecting the viability of 
normal cells, peripheral blood mononuclear (PBM) (Figure 4).16
 
Fgure 4: Cell viability of MCF-7 cell line and PBMC treated with AgNPs16
The anticancer effect  of AgNPs was also reported by  Asharani et al. who exposed normal human 
lung fibroblast cells (IMR-90) and cancerous human glioblastoma cells (U251) to different doses 
of AgNPs in vitro.19 AgNP treated cells exhibited chromosome instability and mitotic arrest in 
human cells. There was efficient recovery from arrest in normal human fibroblasts whereas the 
cancer cells ceased to proliferate. Asharani et al. theorised that the uptake of AgNPs occurred 
mainly through endocytosis, accompanied by  a time dependent increase in exocytosis rate (Figure 
85).19 Toxicity  of AgNPs is mediated through intracellular calcium (Ca2+) channels along with 
significant alterations in cell morphology and surface damages. Exposure of AgNPs to the cells 
resulted in the down regulation of major actin binding protein, filamin.19 The nanoparticles 
induced stress which resulted in an increase (up regulation) in the number of metallothionein and 
heme oxygenase-1 genes. Cancer cells were susceptible to damage without recovery from AgNP 
stress. Silver nanoparticles were found to be acting through intracellular calcium channels and 
chromosomal damages, either directly or through activation of catabolic enzymes. The signaling 
cascades are believed to play key  roles in cytoskeleton deformations and ultimately  to inhibit cell 
proliferation (Figure 5).19 
   
 
Figure 5: The proposed mechanism of AgNP toxicity based on the experimental data obtained by 
Asharani et al.19
91.1.4 Application of AgNPs in Electronic Devices
AgNPs are used in various electronics due to the nanoparticles’ high electrical and thermal 
conductivity along with their enhanced optical properties. Direct ink writing is associated with 
problems such as nozzle clogging. In addressing this problem, Lewis et  al. demonstrated the 
omni-directional printing of flexible, stretchable and bridging microelectrodes using concentrated 
AgNP inks which could readily  flow through micro-nozzles in air without clogging the mozzle 
(Figure 6).20
   a)          b)
Figure 6: Schematic diagram illustrating omni-directional printing and optical image of apparatus 
used (a). Transmission electron microscopy image of the synthesized silver nanoparticles and 
optical image of the concentrated ink (b)20
Also, recently Chan et al. published a direct  approach to optimise the perfomance of organic 
field-effect transistors (OFETs).21 Their finding has potential to address the general severe 
degradation of organic electronic memory devices.21 Chan et al. found that the memory window 
of OFETs widens with increasing AgNPs layer thickness (Figure 7). A maximum window of 90 
V was achieved for 5 nm AgNPs and the on/off current ratio decreased from 105 to 10 when the 
AgNPs layer thickness increased from 1 to 10 nm (Figure 7).21
10
Figure 7: The output characteristics of the transistor memory with AgNPs thickness of 1 nm (a), 5 
nm (b) and 10 nm (c). The transfer characteristics of the transistor memory with AgNPs thickness 
1–10 nm (d)21
1.2 Synthesis of AgNPs
The design and control of AgNPs is crucial in achieving the appropriate properties required for 
many of their different applications. The size, shape, crystallinity, composition and structure 
(hollow versus solid)) of AgNPs are known to strongly depend on the method of preparation.2a-e 
As a result of such many properties of AgNPs that need control during their generation, for 
decades the controlled synthesis of AgNPs of the required characteristics is still a big challenge.
2a-e There are mainly two approaches for the generation of AgNPs which are the top-down and the 
bottom up approaches.22
11
Figure 8: The physical approach versus the chemical approach of AgNP formation22
1.2.1 Top-down Strategy for the Generation of AgNPs
Richard Feynman has advanced the idea of the top-down approach in his 1959 lecture when he 
stated “there is plenty of room at the bottom”.1 The principle behind the top-down approach is to 
take a bulk piece of silver and then modify it  into the desired morphologies of AgNPs. Cutting, 
grinding and etching are typical fabrication techniques, which have been developed to work on 
the nanoscale. The size of the nanoparticles which can be produced with top-down techniques are 
in the range 10 - 100 nm.22 This approach offers precise control over the size and shape, however, 
the point-by-point or layer-by-layer processing makes this approach time-consuming. Another 
drawback of this technique is the generation of imperfections on the surface of nanoparticles. 
Such defects can have a significant impact on the physical properties and surface chemistry of the 
nanoparticles. The top-down approach contributes in less than 4% in AgNP research due to the 
resulting imperfections.2b Even though there are problems connected with the top-down 
approach, this is the method of choice to generate highly complex nanoparticles. Methods of 
generating AgNPs through the top-dowm approach include chemical vapour deposition and laser 
ablation.
1.2.1.1 Chemical Vapour Deposition
The dispersion of Ag0 in a homogeneous nanocrystalline form onto a matrix where nanoparticles 
are generated has been a long challenge. Pal et al. addressed this problem by depositing AgNPs 
embedded in diamond-like-carbon matrix (DLC) onto glass substrates using capacitatively 
12
coupled (13.56 MHz) plasma chemical vapour deposition technique.23 Crystalline AgNPs were 
deposited by using premixed methane and argon gas mixtures in four different proportions of 
argon (50%, 60%, 70% and 80%) in the gas mixture. The plasma was generated between two 
circular aluminum discs. One of the aluminum discs was mounted on the top side of the chamber 
to hold a 1.0 mm thick piece of silver of the same diameter.  The second aluminum disc was 
placed at the bottom of the chamber to hold the glass substrates where the AgNPS were 
deposited. The size of AgNPs was found to increase from 11 to 36 nm with an increase in the 
concentration of Argon (Figure 9).23 It was also observed that  films deposited with different 
amount of argon in the plasma contained AgNPs with nearly  spherical shape. Furthermore, the 
size distribution of AgNPs was narrower for the films deposited with lower concentration of 
argon in the plasma than those deposited with higher amount of argon in the plasma (Figure 9).
Figure 9: TEM micrographs and corresponding histogram of four representative nAg-DLC films 
deposited with different  amount of argon in methane and argon gas mixtures: (a) 50%, (b) 60%, 
(c) 70% and (d) 80%. Insets also show the diffraction patterns of AgNPs23
1.2.1.2 Laser Ablation
Henglein et al. introduced laser ablation of metallic silver as a novel method of AgNP preparation 
without a stabilizer as additive.24a,b Laser ablation and irradiation of pulses of 1 064 nm 
wavelength were employed on Ag foil immersed in water in a quartz cell (Figure 10). This 
procedure was followed by irradiation of pulses of the same wavelength on the solution of 
13
AgNPs without Ag foil to reduce the mean size of AgNPs through fragmentation. The AgNPs 
generated were reported to be of average size of 20 nm but highly polydisperse.
 
Figure 10: Schematic depiction of laser ablation24a 
When the liquid was changed from water to organic solvents like methanol or acetone, the 
nanoparticles were unstable and precipitated completely  overnight at room temperature. Figure 
10 show a schematic depiction of the ablation procedure.24a Many  research groups later modified 
Hanglein’s procedure in order to control the size, dispersity and stability  of nanoparticles. Some 
of the modifications include addition of additives like SDS,25-26 cetyl trimethyl ammonium 
bromide (CTAB)27 and polyvinylpyrrolidone (PVP).28
1.2.2 Bottom-up Strategy for the Generation of AgNPs
Jean-Marie Lehn pioneered the bottom-up approach when he stated “there is plenty  of room at 
the top”.29 The bottom-up approach is also referred to as self-assembly. It involves the 
construction of a structure atom-by-atom, molecule-by-molecule or cluster-by-cluster. This 
approach is simple and flexible, and the building blocks can be designed precisely to facilitate the 
assembly  of nanostructures with tailorable features. The size of the nanostructures that can be 
obtained with a chemical approach spans the full range of the nanoscale.2b 
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An advantage of the bottom-up approach is the possibility  of obtaining nanoparticles with less 
defects and more homogeneous chemical compositions. This is due to mechanisms utilized in the 
synthesis of nanoparticles that reduce the Gibbs free energy, so that the produced nanoparticles 
are in a state closer to a thermodynamic equilibrium.22
Depending on the method of choice in generating AgNPs through the bottom up approach, there 
are several factors which could influence the generation of AgNPs. Such factors include the Ag+-
salt, solvent, type of stabilizer and type of reducing agent for Ag+-ions. 
 Silver salts (Ag+-salts)
The Ag-salt  should dissociate into Ag+-ions for the reduction of the resulting Ag+-ions to take 
place followed by the formation of AgNPs. In the general and specific formation of AgNPs, 
AgNO3 is the most widely used Ag+-salt and accounting for almost 83% of the reported AgNP 
studies (Figure 11).2b Lee and coworkers reported that the wide spread use of AgNO3 is attributed 
to its low cost and chemical stability when compared to other types of Ag-salts.30
  
Figure 11: Analysis of silver salt precursors reported in studies of silver nanoparticle synthesis2b
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 Solvents 
Solvents play critical roles of solubilizing Ag+-salts and other substrates included in the synthesis 
of AgNPs.
  
Figure 12: Analysis of solvents reported in studies of silver nanoparticle synthesis2b
More than 80% of the processes of synthesizing AgNPs use water as the predominant solvent. 
(Figure 12).2b However, the limitation of using water as the solvent is the difficulty  in removing 
the AgNP stabilizer from the surface of the synthesised nanoparticles. Organic solvents make it 
easier to purify AgNPs after their synthesis. 31a,b
 Stabilizing agents
The role of a stabilizing agent in AgNP synthesis is to protect the nanoparticles and prevent them 
from aggregation and also to control the size and shape of the final AgNP products. A stabilizing 
agent blocks the aggregation of AgNPs by producing a protective shell around the forming 
nanoparticles.  Figure 13 shows some of the commonly used stabilizers.2b
Olenin and coworkers reported that the agglomeration of AgNPs is mainly caused by high surface 
energy and high thermodynamic instability of the nanoparticle surface.32 The stabilization 
16
methods can be classified in four categories which are the electrostatic, steric, electrosteric and 
stabilization by a ligand or a solvent.
  
Figure 13: Analysis of stabilizing agents reported in studies of silver nanoparticle synthesis
 Electrostatic stabilization 
Electrostatic stabilization is achieved by addition of ionic compounds like halides, carboxylates, 
or polyoxoanions in the generation of AgNPs.33 An electrical double-layer around the 
nanoparticle develops through adsorption of these ionic compounds and their related counter-
ions. Nanoparticle stabilization is established by Coulombic repulsion between the particles. The 
control of thermal motion or ionic strength is a very  important consideration in stabilizing 
nanoparticles by electrostatic repulsion approach.33
 Steric stabilization  
Steric stabilization involves the use of macromolecules such as polymers, dendrimers or peptides.
34  These macromolecules generate a protective layer on the surface of the nanoparticles (Figure 
14). Aggregation of nanoparticles is prevented by  the restriction in motion of the adsorbed 
molecules in the inter-particle space which results in a decrease in entropy and therefore an 
increase in free energy. Unlike the electrostatic stabilization which is mainly used in aqueous 
solutions, steric stabilization can be used in the aqueous or organic phase.
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Figure 14: Schematic representation of steric stabilisation of metal nanoparticles34 
 Electrosteric stabilization 
The electrosteric stabilization of nanoparticles involves the combination of both the electrostatic 
and steric stabilization methods. Ionic surfactants are generally used for the electrosteric 
stabilization of nanoparticles.35 These stabilizing compounds bear a polar head-group able to 
generate an electric double layer and a lypophilic side chain able to provide steric repulsion. A 
schematic illustration for an electrostatically or sterically stabilized metal nanoparticle.
     a)     b)
      
Figure 15: A schematic illustration for (a) an electrostatically  stabilized metal nanoparticle (M) 
particle (one stabilized by the adsorption of ions and the resultant electrical double layer) and (b) 
a sterically stabilized metal particle (one stabilized by the adsorption of polymer chains)35
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 Ligand stabilization
Ligands coordinate to nanoparticles their preventing them from aggregation. Examples of ligands 
that are used in the synthesis of nanoparticles include phosphines, thiols, amines or carbon 
monooxide and solvents such as tetrahydrofuran or thioethers.36 Balan et al. reported that the 
stability, reactivity, solubility, particle shape and size could all be determined by the concentration 
of a given type of a stabilizing agent.37 Prior findings by Wang and coworkers had also shown 
that smaller sizes of AgNPs are generated by  increasing the concentration of the carboxylate 
stabilizer.38
Overall the selection of the stabilizing agent for AgNPs depends on the intended application. A 
typical example of stabilizer is polynisopropylacrylamide (PNIPAM), a polymer with interesting 
properties for AgNP formation.38 The polymer is commonly used as a temperature-sensitive agent 
and it possesses a lower critical solution temperature (LCST). Guo et al. reported that  below the 
LCST the polymer is hydrophilic and soluble in aqueous solution whereas at temperatures above 
the LCST the polymer becomes hydrophobic, insoluble and aggregates in solution.39 Hence these 
properties make AgNPs capped by PNIPAM  to be used for combined surface plasmon and 
thermal switching applications.39
Another area of AgNP application where the use of a stabilizer could play a great influence is in 
catalysis. Some stabilizers like sodium dodecyl sulfate (SDS) or cetyl trimethylammonium 
bromide (CTAB) decreases the adsorption of reactants to the AgNP surface thereby affecting the 
catalytic efficiency.40 Citrate and PVP are the most widely used stabilizers for AgNPs (Figure 
13).2b The advantages of the citrate are its ability  to act as a stabilizer of AgNPs as well as 
capable of reducing Ag+-ions during the synthesis of nanoparticles.41 The great interest in the use 
of PVP in stabilizing AgNPs is due to the nitrogen in PVP back bone which forms coordinate 
bonds with silver to form the protection layer in the case of particles with diameter lower than 50 
nm. Figure 16 shows general structures of citrate and PVP molecules. For larger particles 
(diameters > 500 nm) both nitrogen and oxygen of PVP are found to form coordinate bonds with 
silver for the stabilization to be effective.42 Such form of electrostatic interactions determine the 
shape and size of anisotropy during the growth of AgNPs.43 
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    a)      b)
    
Scheme 16: Structural scheme of citrate (a) and PVP (b) molecules. In the scheme n represents 
the polymerization number (b)
 Reducing agents for Ag+-ion
The Lee-Meisel44 method which employs sodium citrate as the Ag+-ion reducing agent and the 
Creighton45 method which uses sodium borohydride (NaBH4) as the reducing agent are the 
commonly used chemical methods of generating AgNPs (Figure 17).2b
  
   
Figure 17: Analysis of reducing agents reported in studies of silver nanoparticle synthesis2b
 Lee-Meisel Method
In general citrate is a weaker reducing agent, hence the synthesis of AgNPs takes place under 
heating of the solution.44 Due to the citrate’s weaker Ag+-ion reducing capability, the size of the 
synthesised nanoparticles is relatively large but the nanoparticles are stabilized by the citrate 
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layer which coat the surfaces of AgNPs. The biggest drawback of this method is that the AgNPs 
generated are polydispersed in size.2e
 Creighton Method
An advantage of using NaBH4 is its relatively high reactivity compared to citrate and other 
reductants.2a-e In addition sodium borohydride has moderate toxicity  compared to hydrazine and 
hydroxylamines. Furthermore, NaBH4 has greater lab safety  when compared to hydrogen gas and 
other physical methods.2e However, the AgNPs generated in the presence of NaBH4 are relatively 
small (1-15 nm) and unstable, therefore different stabilizers are used during the synthesis process.
2b Previous studies by Creighton and coworkers showed that the generation of AgNPs in larger 
sizes was difficult to control when NaBH4 was used as the Ag+-ion reducing agent.45
In most cases the generation of AgNPs in different sizes has been successfully achieved by using 
ascorbic acid which is a weaker Ag+-ion reducing agent than NaBH4 but is a stronger reducing 
agent than citrate.2b
The synthesis of silver nanoparticle by the bottom up approach can be arbitrarily divided into two 
main categories which are the photochemical and chemical generation methods.
1.2.2.1 Photochemical Method of Generating AgNPs 
An important challenge in the synthesis of AgNPs is to control nanoparticle size and shape while 
maintaining a high overall yield of product. Photochemical method was the first reliable and high 
yielding method for making solution phase triangular Ag nanoprisms.46 Moreover, photochemical 
methods of generating AgNPs can offer advantages such as fast reduction of Ag+-ions at ambient 
temperature. In addition, the reduction can be initiated homogeneously thereby avoiding local 
concentration gradients when reactants are mixed. The use of a stabilizing agent is crucial to 
prevent the aggregation of the generated nanoparticles. Pal et al. introduced ascorbic acid which 
is a photoactive molecule in the photochemical method of generating AgNPs.46 They  reported 
that their method of using an ordinary hand-held 15 W germicidal lamp as the source of light, 
was reproducible, simple and rapid (AgNP formation was complete in less that 5 minutes). TEM 
studies show that the individual particles are polydisperse and are in the size range of 15 - 60 nm 
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(Figure 18). Furthermore, the generated nanoparticles form assemblies of approximately  300 nm 
in size.
! ! ! !
Figure 18: TEM images of the AgNPs generated by the photochemical method46
In 2001 Mirkin et al. reported the first high yield synthetic method for triangular shaped Ag-
nanoprisms by use of visible light.47 The conversion of the nanoparticles to nanoprisms could be 
turned on and off simply  by turning on or off the light source. Visible light was irradiated onto a 
solution containing trisodium citrate, bis(p-sulfonatophenyl)phenylphosphine dipotassium salt 
(BSPP) and AgNP seeds of diameter 6 to 8 nm. In this system, the citrate was the photoactive 
agent whereas BSPP stabilized the generated AgNPs. Spherical AgNPs were almost completely 
converted by visible light into thin triangular prisms with edge lengths of 100 ± 15 nanometers 
(Figure 19).
Figure 19: TEM images (A) before irradiation and after (B) 40, (C) 55, and (D) 70 hours of 
irradiation. Except for the inset in (A), the scale bar is 200 nm for all three images47
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Following Mirkin et al.‘s initial report of triangular Ag nanoprism synthesis, other researchers 
have confirmed the results and significantly expanded upon their scope. For example, Brus et al. 
observed morphological changes of spherical AgNPs to nanoprisms when the spherical AgNPs 
were exposed to various wavelengths of visible light.48 Irradiation of a solution of Ag+-ions, 
AgNP seeds and citrate with a 457 nm laser led to the generation of Ag-nanoprisms which 
increased in size from 14 to 50 nm after 5 and 90 minutes of irradiation respectively (Figure 20). 
Citrate served as a photoactive Ag+-ion reducing agent  as well as a stabilizing ligand for the 
AgNPs. When this reaction was monitored over time using TEM, Brus et al. observed increasing 
numbers of Ag nanoprisms with increasing irradiation time.48 Furthermore the authors reported 
that the irradiation time and the concentration of Ag+-ions in solution control the final size of the 
particles whereas the shape strongly depended on the excitation wavelength.
	

 	

 	

 	


Figure 20: TEM  pictures of AgNPs synthesized after 5 (A), 10 (B), 15 (C), 20 (D), 50 (E) and 90 
(F) minutes of irradiation with a 457 nm laser48
Brus et al. proposed that  the excitation of a specific plasmon determines the growth direction of 
AgNPs.48 Due to the shape dependence of the Ag0 plasmon resonance, the aspect ratio of 
nanoparticles is controlled by  the irradiation wavelength. Therefore, an increase in the irradiation 
wavelength leads to an increase in the aspect ratio of nanoparticles. Brus et al. supported their 
hypothesis by  using a 457 nm laser to irradiate Ag-nanoprisms (generated in the presence of a 
23
457 nm laser) together with a solution of AgNO3 and citrate.48 The resulted nanoprticle size 
increased but their aspect ratio remained constant. However, irradiation with a laser of longer 
wavelength 514 nm resulted in the formation of Ag nanoprisms of a larger aspect ratio.
Despite the great effort which has been done to prepare AgNPs, the generation of AgNPs in 
defined shape variety and size remain a big and important challenge. Photo induced methods of 
AgNP synthesis have been used to generate defined Ag nanoprims, however quite often the 
processes need several hours to prepare these nanoparticles in defined shape. Also, most light 
sources which are used for the generation of AgNPs of defined sizes and shapes are expensive.
1.2.2.2 Chemical Reduction Method of Generating AgNPs
The chemical reduction method is the most frequently  applied method for the preparation of 
silver nanoparticles due to its easy  accessibility. Along with that, the chemical method is 
generally  cheaper in the costs involved in the generation of AgNPs. In addition this approach 
offers possibility of generating a variety  of AgNPs of defined size and shape.49 When Ag+-ions 
are reduced they form Ag0 atoms which eventually  agglomerate into oligomeric clusters and 
finally lead to AgNPs.49a Due to the large positive reduction potential of Ag0, AgNP oxidation is 
thermodynamically unfavorable resulting in quite stable aqueous and alcoholic suspensions 
without the aid of capping ligands. The thick electrical double layers that form around metal 
nanoparticles in low-ionic-strength suspensions can inhibit aggregation. For high ionic strengths 
or organic-phase suspensions capping agents such as surfactants or polymers can be employed to 
protect the particles from aggregation.50 Typical surfactants used for AgNPs include sodium 
dodecyl sulfate, oleic acid, alkyl phosphines and hexadecylmine. Common polymers which are 
used comprise of poly(vinyl pyrrolidine) (PVP) and polyethylene glycol (PEG). If the synthesis is 
carried out in the presence of capping agents, however, anisotropic particles may  result due to the 
differing affinities of the ligands to the exposed crystal faces. For example Xia synthesised 
monodisperse Ag nanocubes in large quantities by reducing AgNO3 with ethylene glycol in the 
presence of poly(vinyl pyrrolidone) (PVP) (Figure 21).51 The authors reported that the selective 
adsorption of PVP on various crystallographic planes of AgNPs played the major role in 
determining the product morphology.
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Figure 21: (A) Low- and (B) high-magnification SEM images of slightly  truncated silver 
nanocubes synthesized in the presence of PVP and ethylene glycol as the reducing agent of Ag+-
ions. The image shown in (B) was taken at a tilting angle of 20°51
Previous studies by  Pileni et al. have also shown that judicious use of stabilizing agents generates 
AgNPs of a variety  of shapes.52 Sodium di(2-ethyl-hexyl)sulfosuccinate (Na(AOT)) was used to 
stabilize AgNPs whereas hydrazine was the Ag+-ion reducing agent. After the synthesis, single-
crystal Ag nanoprisms in equilibrium with spheres were produced. The amount of reducing agent 
tuned the nanodisc size (between 30 and 100 nm by the relative amount of reducing agent) but 
did not affect the aspect ratios of the nanodiscs, hence the shape remained the same (Figure 22).
       
Figure 22: Ag nanoprims as observed by  TEM at [(hydrazine]/[ AOT] of 5.35 (A), 6.6 (B), 8.2 
(C)52 
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Regardless of their good performance in controlling the size and shape, additives like surfactants 
or polymers very frequently make part of the AgNP compositions hence impact the physical, 
chemical and biological properties of such nanoparticles.2a-e Depending on the intended area of 
application, in many cases these additives limit the application of AgNPs generated in their 
presence. As an example, the toxicity of these additives make them non-compatible with 
biomedical applications. To avoid this major drawback, recently peptides bearing functional 
groups that coordinate to Ag+ ions have become popular as additives.2a,d
Moreover peptides display self assembly and recognition properties which make them useful as 
building blocks for binding and promoting the nucleation and growth of AgNPs.2a,d Other 
advantages of using peptides besides their ability to control the structure and size of AgNPs, are 
their potential to improve nanoparticle dispensability and chemical stability. 
 Biosynthesis of AgNPs
Biosynthesis is one of the chemical methods of synthesising AgNPs.2a Due to a growing need to 
develop environmentally friendly methods in nanoparticle synthesis, the biosynthesis has 
received increasing attention in AgNP generation.53 Klaus and coworkers reported for the first 
time the intracellular biosynthesis of AgNPs which was performed using a bacterial strain 
Pseudomonas stutzeri AG259. The growth of cells in the presence of Ag+ was accompanied by 
the formation of AgNPs in diameters of up  to 200 nm in the periplasmic space of cells (Figure 
23).54,55
Since the mechanism of AgNP formation under these conditions is still unclear, proteins with 
affinity for silver and containing fragments capable of acting as the nucleation sites were 
assumed to play a key role in the formation of AgNPs. It was speculated that the reduction of Ag
+-ions proceeded by  an extracellular mechanism by proteins from the cell wall structure of the 
fungus.54-55
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Figure 23: Different morphologies and sizes of AgNPs generated by P. stutzeri AG259. (a) TEM 
image of bacteria cell showing triangular Ag nanoprisms at both poles and an accumulation of 
smaller AgNPs all over the cell. (b and c) TEM images of triangular, hexagonal and spheroidal 
AgNPs accumulated at different cellular binding sites54
Sastry et al. also showed that  the fungus Fusarium oxysporum is capable of extracellular 
reduction of Ag+-ions to afford AgNPs with diameter of 5 to 15 nm (Figure 24).56 
    
Figure 24: TEM  micrograph recorded from a drop-coated film of an aqueous solution incubated 
with Fusarium oxysporum and reacted with Ag+-ions for 72 h. The scale bar corresponds to 100 
nm
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In order to understand the biosynthesis of AgNPs, Esposito et al. published the mechanism of Ag
+-ion reduction by different strains of Fusarium oxysporum.57 The authors reported that the 
scanning electron microscopy (SEM) data showed well-isolated AgNPs in the range of 20 to 50 
nm in dimensions Figure 25.
   
Figure 25: SEM micrograph from F. oxysporum showing silver nanoparticles recorded at  X40 
000 magnification57 
Fluorescence and visible absorption spectra of the solutions of AgNPs revealed that the 
stabilizing proteins contained tryptophan and tyrosine and were in their native form. However, 
the spectroscopic studies also showed the presence of 2-acetyl-3,8-dihydroxy-6-methoxy 
anthraquinone or its isomer 2-acetyl-2,8-dihydroxy-6-methoxy anthraquinone as well as the 
presence of NADP-dependent nitrate reductase.57 Previously Kolter et al. had reported that the 
isomers which were observed act as extracellular electron carriers.58 Hence Esposito et al. 
postulated that the mechanism of Ag+-ion reduction could include the conjugated oxidation-
reduction reactions of electron carriers in which NADP- dependent nitrate reductase is involved 
(Figure 26).57
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Figure 26: Hypothetical mechanisms of extracellular reduction of Ag+-ions by a strain of fungus 
Fusarium oxysporum57 
Even though the biosynthesis of AgNPs does not apply a stabilizing agent since the organic 
matrix of the bacteria is involved in stabilizing the nanoparticles and is a green process,54 it  is 
rather a slow process that can even take several days.59 Only a few fast methods have been 
reported where bacteria is used to generate AgNPs.59 The general understanding of the generation 
and growth of AgNPs through the bio-inspired synthesis are poorly understood, other approaches 
like the biomimetic synthesis have already been explored as possible solutions.2d
A rational prediction of a diversity of peptides capable of inducing the formation of AgNPs of 
different sizes and shapes is difficult. 2d In order to address this problem combinatorial library 
approaches such as phage display libraries have been applied.60,61
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1.2.2.2.1 Phage Display Libraries and Biomimetic Synthesis of AgNPs
Naik et al. undertook the first  studies aimed at identifying peptides that bind to and are able to 
induce the formation of AgNPs60,61 They  used a phage display peptide library to identify  the 
active peptides in generating AgNPs (Figure 27). 
Figure 27: Procedure for the isolation of peptides possessing a high affinity for silver substrate 
from a phage-displayed library. Several (3-5) rounds of stringent washing and elution are used to 
remove weakly binding peptides from the final screened phage population. The amino acid 
sequence of the displayed peptide is determined through the DNA sequencing of the final phage 
clones1d
Screening of a phage display library  involves many steps.61 The phage library in a buffer solution 
is incubated with a Ag-salt resulting in a heterogeneous mixture of phages in contact with the 
silver substrate. Several washing cycles of the phages eliminate non-binders by  disrupting weak 
interactions with the silver substrate. Bound phages are next eluted from the surfaces and 
amplified by reinfecting the host thereby completing the first round of biopanning. Generally, 
three to five cycles of biopanning are repeated using increased concentrations of the buffer in 
order to enrich for tight binders. Finally, individual clones are sequenced to obtain the amino acid 
sequence of the peptides binding to the silver substrate.62
Through phage display  screening, Naik et al. identified peptides AYSSGAPPMPPF and 
NPSSLFRYLPSD that proved capable of reducing silver ions and directing the formation of 
AgNPs.61 The identified silver-binding peptides indicated a preferential enrichment of proline and 
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hydroxyl-containing amino acid residues. Peptide NPSSLFRYLPSD was found to direct the 
formation of hexagonal, spherical, and triangular shaped AgNPs of 60 - 150 nm in size (Figure 
28). This peptide is reported to bind specifically to the Ag(111) surface and thus enables the 
synthesis of polyhedral Ag crystals with face-centered-cubic lattice structures.
   
Figure 28: TEM image showing a variety of crystal morphologies of AgNPs obtained using 
peptide NPSSLFRYLPSD (a-d), electron diffraction pattern obtained from a AgNP (b) and edge 
of the truncated triangle showing the thickness of the plate (d)60
In another study Naik et al. introduced polymerase chain reaction (PCR)-driven peptide screening 
method to isolate peptides that induce the formation of AgNPs.61 PCR was introduced as a 
versatile technique that could identify peptide sequences which possessed high affinity to silver 
that these sequences resisted elution and identification by  standard biopanning procedures.61 
Figure 29 depicts the general scheme for the PCR screening procedure. 
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Figure 29: Schematic illustration of general PCR driven phage panning for peptides that bind to 
inorganic nanoparticles61
Several peptides were identified to be able to induce the formation of AgNPs (Table 1). Among 
the peptides identified peptides WSWRSPTPHVVT induced the formation of spherical 
nanoparticles of 52 ± 13.2 nm in size (Figure 30). Results from these reported phage display 
screening studies show that different peptides can induce different sizes of AgNPs. 
KFLQFVCLGVGP   AVLMQKYHQLGP   IRPAIHIIPISH 
NVIRASPPDTSY   LAMPNTQADAPF   QQNVPASGTCSI 
NAMPGMVAWLCR   HNTSPSPIILTP   ASQTLLLPVPPL 
YNKDRYEMQAPP   TLLLLAFVHTRH   PWATAVSGCFAP 
SPLLYATTSNQS   WSWRSPTPHVVT
Table 1: Silver-binding peptides identified by PCR screening technique61
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Figure 30: TEM image of AgNPs generated in the presence of peptide WSWRSPTPHVVT
Furthermore the importance of peptides was demonstrated as studies which were done by Naik 
and coworkers on single amino acid solutions of lysine, proline, serine, and arginine showed 
incapability  in generating AgNPs. Moreover, tryptophan and aspartate that were used by Sastry et 
al to reduce Au+3-ion in the synthesis of gold nanoparticles did not show the ability  to reduce Ag
+-ions.63 Conformation, overall charge, and functional groups of peptides could all be 
contributing to the reduction of Ag+-ions and the subsequent formation of AgNPs. 
Following Naik et al.’s breakthrough in using the phage display libraries in identifying peptides 
that are able to generate AgNPs, Bassindale and coworkers have also undertaken the screening of 
phage-displayed peptide libraries to identified silver-binding peptides.64 From the peptides 
identified, two peptide sequences TVPPKAPRSSDL and LTRPNHGNTVDT were reported to 
generate distinct morphologies of AgNPs.64 
Xie et  al. employed proteins extracted from the green algae C. Vulgaris and generated Ag 
nanoplates of size 44 nm in average diameter and in one-pot synthesis process (Figure 31).65 
Following chemical modifications of the algae protein they found that tyrosine residues were the 
source of bio-reduction of Ag+ and the carboxyl groups in Asp and/or Glu were primarily 
responsible for the anisotropic growth of the Ag nanoplates.65 Rational designed tripeptides also 
demonstrated that tyrosine residues in a peptide could reduce Ag+-ions.65 Furthermore they 
published that the acidic residues comprising Asp and Glu are involved in directing the 
anisotropic growth of AgNPs.65 
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Figure 31: TEM  image of the AgNPs synthesised by the green algae C. Vulgaris. The arrows 
point to locations where several flat particles had overlapped
In another study Wright et  al. isolated peptide AHHAHHAAD from the histidine-rich protein of 
Plasmodium falciparum and used it in the formation of AgNPs of 7 nm in average size.66
To date many scientists have invested much effort to understand the relationships between 
peptide sequences and their influence in the generation of nanoparticles. For example Xie et al. 
used rationally  designed simple tripeptides as a proof of concept for the biomimetic synthesis of 
Ag nanoplates and to further test the nanoparticle formation mechanism (Table 2).65 Furthermore, 
they  investigated the Tyr Ag+-ion reducing power in the presence of different amino acids in a 
peptide. Peptide Gly-Tyr-Tyr, was the fastest in reducing Ag+-ions. Since peptide Gly-Gly-Gly 
does not contain a tyrosine residue, it showed no apparent formation of AgNPs.
Gly-Gly-Gly  His-His-Tyr
Gly-Gly-Tyr Lys-Lys-Tyr
Gly-Tyr-Tyr Asp-Asp-Tyr 
Cys-Cys-Tyr Ser-Ser-Tyr
Table 2: Silver-binding peptides identified by PCR screening technique65 
Intriguingly, the presence of peptides His-His-Tyr and Cys-Cys-Tyr resulted in no formation of 
AgNPs. For peptides Lys-Lys-Tyr and Asp-Asp-Tyr the binding of the Ag+-ions at the amine on 
Lys or carboxylic sites on Asp was found to be weaker than in the case of binding with the 
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imidazole on the His-His-Tyr or thiol on Cys-Cys-Tyr sites. Therefore, Ag+-ion reduction was 
found to be slower in the presence of peptides Lys-Lys-Tyr and Asp-Asp-Tyr than in the presence 
of peptides Gly-Gly-Tyr and Ser-Ser-Tyr. The ratio of carboxylic groups to Tyr per peptide 
molecule was found to be an important consideration in the high yield of Ag nanoplate formation.
65 
In order to have more in depth knowledge on the influence of peptides in the formation of 
AgNPs, Mandal and coworkers used peptides NH2-Leu-Aib-Trp-OMe and Boc-Leu-Aib-Trp-OH 
in the generation of AgNP and AuNPs.67 Even though results on AgNP formation in the presence 
of both peptides was not fully  reported, the influence of both peptides in the formation of AuNPs 
is well-outlined. Interestingly they found that peptide Boc-Leu-Aib-Trp-OH generated AuNPs of 
7.33 ± 0.8 nm in size and better size distribution than peptide NH2-Leu-Aib-Trp-OMe which 
generated bigger sizes of AuNPs in average diameter of 13.39 ± 2.7 nm (Figure 32). Due to the 
absence of free amino groups in peptide Boc-Leu-Aib-Trp-OH the stability of AuNPs which were 
generated in its presence was less than the stability of AuNPs prepared in the presence of peptide 
NH2-Leu-Aib-Trp-OMe.67
   a)       b)  
   
Figure 32: TEM images of AuNPs prepared in the presence of peptides NH2-Leu-Aib-Trp-OMe 
(a) and Boc-Leu-Aib-Trp-OH (b)
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The authors reported that peptide NH2-Leu-Aib-Trp-OMe induced the formation of AgNPs of 
13.66 ± 2.0 nm in size which is comparable to the average size of AuNPs synthesised in the 
presence of the same peptide (Figure 33).67
    
Figure 33: TEM image of AgNPs prepared in the presence of peptide NH2-Leu-Aib-Trp-OMe  
Banerjee et al. also published on the reduction of Ag+-ions by tyrosine residues which were 
incorporated into the gel forming tripeptides for the in situ generation of AgNPs (Figure 34).68 
The formation of AgNPs involved heating above 50 °C the methanol-water gel of tyrosine 
tripeptide and AgNO3 until the appearance of a clear solution.
    
Figure 34: Gel forming tyrosine tripeptide used for AgNP formation within the gel-phase 
network.
Upon slow cooling the clear solution turned yellow indicating the formation of AgNPs through 
reduction of Ag+-ions by tyrosine residues within the tripeptide. The formation of AgNPs 
embedded in the tripeptide gel was rapid and took place immediately after the solution turned 
yellow.68 Stabilization of AgNPs was achieved by the peptide’s gel matrix.
36
Phage display library  approach is a very  powerful, successful and conventional panning method 
of identifying a variety  of peptides which are able to induce the formation of AgNPs.1 However 
the approach has its own shortcomings. For example the use of acid to release the phage from the 
silver substrate may selectively liberate predominantly  basic peptides which could again be 
enhanced with each round of panning. In addition, the PCR method gives fragments of phage 
DNA so performing a second round of panning requires several time-consuming manipulations. 
Further analysis and studies of the properties of the peptide also require expensive individual 
syntheses. Moreover the peptides for the synthesis of AgNPs which are selected by screening of 
phage display libraries have varying compositions and structures making it difficult to understand 
peptide sequence-AgNPs size, shape and stability relationships. Furthermore, the peptides 
comprise of random and inactive amino acid sequences that also complicate the understanding of 
their influence in the formation of AgNPs.61
A different technique that does not only screen for peptides that bind to Ag0 but also for Ag+ 
could play an advantage. Such a technique could out-perform the phage display approach if it can 
be screened at milder conditions but still able to efficiently identify  peptides that induce the 
formation of AgNPs in different sizes. Encoded split-and-mix library strategy could be techniques 
which can be used to address these drawbacks in the identification of peptides that induce the 
formation of AgNPs.
1.3 Combinatorial Chemistry
Combinatorial chemistry  is an excellent tool where rational prediction reaches its limits. The 
principle of the approach is to synthesize a large number of different molecules ("library"), screen 
them simultaneously and select the active members. This can be viewed as the chemist’s attempt 
to imitate nature’s principles of random mutation and selection for the fittest. 
The capacity to produce a large variety of molecules and the existence of effective screening 
methods to identify active members of the library are the two factors which determine the success 
of a combinatorial method. 
In the last decades there has been rapid growth of interest in the application of combinatorial 
chemistry in many  fields like drug discovery,69 catalyst development70-71 and material science.
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72-73 Several strategies have been developed to generate molecular diversity.74-75 One-bead-one-
compound library synthesis via split-and-mix strategy is one of the most elegant methods to 
create highly diversified pools of small molecules.76-77
1.3.1 One-Bead-One-Compound Synthesis
Lam and coworkers were the first to recognize the one-bead-one-compound strategy (OBOC).  It 
is a concept that is based on the fact that one single compound is localized on one single bead that 
is prepared via a split-and-mix synthesis.79 The principle for the generation of one-bead-one-
compound libraries relies on successive cycles of splitting the solid phase resin into equal 
portions (step 1 of Figure 35). Subjecting each portion to a different reaction (step  2). The 
modified resin portions are combined and mixed (step 3) and are ready for splitting again into 
equal portions for the next synthesis cycle. This approach leads to an exponential increase of the 
diversity of products relative to the number of reactions performed. After x reaction cycles with n 
different reactions performed in each cycle the maximal number of compounds equals nx. Since 
each bead has been subjected to only  one reaction during each cycle, therefore each bead carries 
only one compound. This approach allows for the synthesis of a large number of compounds with 
relatively few reaction steps (Figure 35).
At the end of synthesis, depending on the resin loading, picomole quantity of compound is 
localized on each bead. This amount is sufficient to analyse via Edman degradation, however this 
method is restricted to linear peptides and do not allow the use of non-natural amino acids or 
totally  different building blocks. Mass spectrometry80-82 as well as 13C-NMR and 1H-NMR83-84 
(especially to large beads) are possible but the distinction of compounds with identical mass is 
rather difficult if not impossible by  these methods. An alternative approach known as encoding 
technique was then introduced.85 
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Figure 35: Split-and-mix synthesis
1.3.2 Encoded Split-and-Mix Synthesis
The principle of encoding relies on the attachment of molecular tags in each reaction vessel of 
each cycle to the resin beads that can be later cleaved off and analysed easily  and unequivocally. 
Since each reaction step is encoded (Figure 38), the tags can report the synthetic history of the 
corresponding bead. The beauty about encoding is that the analysis can even be performed when 
the compound of interest has been modified during the screening.
The first molecular tags used were oligonucleotides86 and oligopeptides.87 However, their use had 
some disadvantages such as instability to numerous reaction conditions. Ideally, tag molecules 
should have the following properties: 
 a) inert under various reaction conditions, 
 b) easily detectable on a very small scale,
 c) easily attached and detached from the solid support.
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The poly-halogenated aromatic alcohols shown in Figure 36 have been found to fulfill these 
requirements.88-89 They can be analysed on a 1 picomole scale by gas chromatography coupled to 
electron capture detection (EC-GC) since this detection method is very sensitive to halogenated 
compounds.
Figure 36: Tag alcohols used for library encoding
Variations of the halogen pattern as well as the hydrocarbon chain lengths result in different 
retention times in the EC-GC analysis. The tag alcohols are coupled either via a carbonate bond 
to 3-nitro-4-hydroxymethyl-benzoic acid88 or via an ether bond to vanillic acid89 which serve as 
linkers to the solid support (Figure 37). Irradiation with UV-light in case of the nitrobenzoic acid 
or oxidation with ceric ammonium nitrate (CAN) releases the tag alcohols for EC-GC detection.
Figure 37: Linkers to attach the tags to the solid support
For encoding the reactions, a binary  code is used whereby each reaction step is encoded by  an 
array  of tags rather than by one single tag and this allows for encoding of a large number of 
compounds.88 As illustrated in Figure 35, given two tags (T1 and T2), T1 encodes for reaction A 
and T2 for reaction B while the combination of T1 and T2 can be used to encode for reaction C 
(rather than a third tag). Therefore, the binary encoding scheme allows the encoding of 2N-1 
reactions with N different tags.88,89
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Figure 38: Encoded split synthesis
Since the detection sensitivity  (1 pmol) of these tags is so high, only  1-2mol% of tags regarding 
the bead loading is sufficient for analysis. For peptide libraries, the tag molecules can be attached 
to the free N-terminus before the amino acid is coupled.
1.3.3 Screening Encoded Combinatorial Libraries
Combinatorial chemistry  is a powerful tool that relies on the simultaneous screening of thousands 
of compounds in “on-bead screening” rather than testing each compound individually. In order, to 
visualize the selective binding of a receptor to a substrate, the receptor is marked with a dye or 
fluorescent molecule.90 Such a dye-receptor conjugate system is then equilibrated with an on-
bead library. The colour of the receptor concentrates on those beads carrying ligands with affinity 
for the receptor. 
Visual inspection of the coloured beads is done through a low power microscope. A statistical 
representation of the coloured beads is then isolated, the tags cleaved from the beads and 
analysed by ECGC technique to reveal the structure of the active compounds (Figure 39).
41
 
Figure 39: On bead screening of a dye marked receptor against an encoded library
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II.
OBJECTIVE
Since a rational prediction might be difficult to identify a wide variety of peptides that induce 
AgNP formation, combinatorial approaches are attractive for the identification of suitable 
peptides.2a,d Herein, we envisaged colorimetric on-bead screening of split-and-mix libraries to be 
powerful tools that could allow for the identification of peptides which can induce AgNP 
formation in different size.91-92 The typical size- and shape-dependent coloration of AgNPs2a-e is 
anticipated to allow for a facile identification of active library members.
Therefore, the objective of this research was to identify, through combinatorial split-and-mix 
libraries, peptides that are able to induce the formation of AgNPs. The identified peptide hits 
were resynthesized and then evaluated as individual sequences for the formation of AgNPs on 
solid support. In subsequent studies, the ability of these peptides to induce the formation of 
AgNPs in solution and the possible formation kinetics were further explored to gain insight into 
the possible roles of peptides.
Since AgNPs are known to be antibacterial, studies were also carried out on the antibacterial 
activity of the AgNPs generated in the presence of different peptides.
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IV.
RESULTS AND DISCUSSION
The aim of this thesis was to carry out solution phase studies and investigate how short peptides 
identified within split-and-mix-library  1 shown in Figure 40 (synthesized and screened by Dr. 
Kirsten Belser)1,2 could be used to induce the formation of different sized AgNPs. In this regard, 
the effect of pH, peptide/Ag+ ratio and the role of the linker between the amino acids were 
evaluated. Accompanying this account, are studies carried out using Isothermal Micro 
Calorimetric (IMC) technique on the antibacterial activity of the generated AgNPs.
  
Figure 40: General structure of peptide library 1
4.1 Preliminary Experiments to the Generation of Silver Nanoparticles
Before the synthesis of library 1, preliminary experiments were carried out (by Dr. Kirsten 
Belser)1 to investigate the efficiency  of calorimetric on bead (Tentagel resin) visualization of 
AgNPs. Tentagel resin was functionalized with isonicotinic acid, a well-known Ag-complex 
ligand.1,3 Acetylated Tentagel was used as control (Figure 41).  
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 Isonicotinic acid coupled Tentagel     Ac-­‐Tentagel
Figure 41: Scheme of the isonicotinic acid coupled Tentagel and acetylated Tentagel1,3
Tentagel resin functionalized with isonicotinic acid and the acetylated form were treated with an 
aqueous solution of AgNO3 (0.05 M). To guarantee a 100% uptake, the ratio of Ag+-ions to 
isonicotinic acid loading on the resin was approximately 10:1. The Ag+-ion treated Tentagel resin 
was then washed with nanopure water to remove the uncomplexed Ag+-ions, followed by the 
reduction of the complexed Ag+-ions with an aqueous solution of sodium ascorbate (0.05 M).
Analysis of the treated resin under a light microscope showed red coloured beads for the 
isonicotinic acid Tentagel beads whereas the acetylated Tentagel beads remained colourless 
(Figure 42).1,4 The formation of colour indicates the presence of AgNPs on the surface of 
isonicotic acid Tentagel, which was confirmed by  Scanning Electron Microscopy  (SEM) studies 
(Figure 43). SEM  studies revealed AgNPs of sizes up to 500 nm in diameter localized on the 
surface of isonicotic acid Tentagel beads. Acetylated Tentagel beads, a control, did not show any 
evidence of AgNPs on the surface of beads.       
    
Figure 42: Light micrograph of AgNPs on isonicotinic acid functionalised Tentagel1,4
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   a)       b)
Figure 43: SEM images (a and b) of AgNPs on isonicotinic acid functionalised Tentagel1,4 
Thus, results shown on the image of beads from these experiments served as proof of concept of 
using the colourimetric on bead screening of AgNPs.
4.2 Split-and-Mix Synthesis of Encoded Library 1
Library 1 was used in our investigations to identify  peptides which are able to induce the 
formation of AgNPs. The library was prepared by  encoded photocleavable tags5,6 split-and-mix 
synthesis7,8 (see Chapter 1.3.2) on Tentagel resin by  utilizing seven different linkers and seven 
different L- and D-amino acids in positions AA1 and AA2. In library 1, positions AA1 and AA2 
consists of histidine (His), aspartic acid (Asp), serine (Ser), and tyrosine (Tyr), amino acids 
whose side groups contain N- and O- functional groups that were expected to coordinate to Ag+ 
(Figure 40). Since the Tyr moiety reduces Ag+-ions,9,10 its inclusion in the library was to allow the 
investigation of its influence in the formation of nanoparticles in solution. Amino acids in 
positions AA1 and AA2 were linked by linkers of varying flexibility  and geometry to allow for 
diverse spatial arrangements of their side-chain functional groups. Aminoisobutyric acid (Aib), 
Pro-Aib, trans-2-Aminocyclohexanoic acid (Achc) and Pro-Gly were chosen as turn-inducing 
linkers whereas β-alanine, glycine (Gly) and 6-aminohexanoic acid (Ahx) as flexible linkers. At 
the end of the synthesis the library  consisted maximally of 73 = 343 different peptides (Figure 
40), each localized on a single bead. 
51
Amino acid couplings were performed by following the standard Fmoc/tBu protocol for peptide 
synthesis using HCTU/iPr2NEt as the coupling reagent and piperidine for Fmoc deprotections 
(Fmoc = 9-fluorenylme-thyloxycarbonyl, HCTU = 2-(6-Chloro-1H-benzotriazole-1-yl)-1,1,3,3-
tetramethylaminium hexafluorophosphate).
4.3 Combinatorial Screening of Encoded Split-and-Mix Library 1
Library 1 was then used to identify peptides which can induce the formation of AgNPs. Typically 
different sizes and shapes of AgNPs display different colours, a property utilized in the screening 
studies.11 The screening involved the incubation of library 1 with an aqueous solution of AgNO3 
followed by several washing steps with nanopure water to remove the excess of silver ions. 
Sodium ascorbate was then used to reduce Ag+-ions which were complexed to the peptides on the 
beads. Within ten minutes several beads became coloured and the colour ranged from yellow and 
light orange to dark red (Figure 44). Different colours are indicative of AgNPs of different sizes.11 
Therefore, this result suggests that  different peptides within the library induce the formation of 
AgNPs of different sizes upon chemical reduction of the Ag+-ions. This hypothesis was 
confirmed by SEM studies, which clearly  demonstrate the formation of AgNPs on the coloured 
beads (Figure 44).4
Several coloured beads from each colour category of the assay were isolated. Following DMF 
washing of the beads, they were irradiated under high intensity UV light, liberating the tag 
alcohols contained on each bead. Subsequent EC-GC analyses of the sequences on the beads 
revealed Tentagel bound peptides bearing a histidine (His) residue in combination with either an 
aspartate (Asp), a serine (Ser) or a tyrosine (Tyr) residue give red or dark orange coloured beads 
whereas combinations between Tyr and Ser or Asp give yellow coloured beads (Table 3). 
Interestingly, linker type did not affect the colour, suggesting that the relative orientation of the 
two amino acids in a peptide is not crucial for their activity. Furthermore there was no 
pronounced selectivity for L- or D-configured amino acids which also indicates that the 
stereochemistry of the amino acids does not play a crucial role in the formation of AgNPs on the 
bead (Table 3).
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Figure 44: Library 1 after Ag+ incubation and sodium ascorbate reduction of Ag+, light 
microscopic (a) and SEM images (b, c and d)4
Bead colour Active peptide
Red/dark orange Ac-His-X-His-resin
Ac-His-X-Asp-resin
Ac-Asp-X-His-resin
Ac-His-X-Tyr-resin
Ac-Tyr-X-His-resin
Ac-His-X-Ser-resin
Ac-Ser-X-His-resin
Light orange/yellow Ac-Asp-X-Asp-resin
Ac-Ser-X-Tyr-resin
Ac-Tyr-X-Ser-resin
Ac-Asp-X-Ser-resin
Ac-Ser-X-Asp-resin
X = random linker
Table 3: Peptide consensus sequences on differently coloured beads
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  4.4 Ag-Nanoparticle Formation by Immobilised Peptides 2a-4b
Based on the combinatorial screening results, we decided to look into further the ability of the 
active peptides to generate AgNPs as individual sequences as well as to validate the 
combinatorial screening results. Several representative samples of the identified peptides from 
each colour category were resynthesized on Tentagel resin. Peptides were resynthesized in order 
to evaluate the influence of the linker and the role of Tyr in the formation of AgNPs. Most 
importantly, the peptides chosen were expected to give better understanding of how the formation 
and size of AgNPs depend of the different peptides. Among several active peptide sequences 
resynthesized and evaluated for the AgNP formation, in this thesis peptides which showed higher 
frequencies from the combinatorial results are discussed. 
Peptide sequences containing His with His (peptides 2a-b) found on dark red coloured beads, His 
with Asp (peptides 3a-b) found on light red coloured beads and Ser with Tyr found on yellow 
beads (4a-b) were resynthesised. To evaluate the effect of the nature of the linker, the sequences 
contain an aminohexanoic acid (Ahx) moiety as flexible linker (2a, 3a and 4a) or a proline-
glycine (ProGly) as rigid linker (2b, 3b and 4b) (Figure 45). These linkers which we chose were 
all hits in the combinatorial screening experiments. 
Scanning Electron Microscopy was used to characterize AgNP size and their distribution, and to 
understand the formation of the nanoparticles. For the determination of the loading of Ag+-ions 
on Tentagel beads localized with different peptides, we used Atomic Absorption Spectroscopy 
(AAS).
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  2a       2b
  
  3a       3b
  
  4a       4b
Figure 45: Structures of peptides 2-4 used for the AgNP formation on Tentagel solid support.
Peptides bound on Tentagel resin were treated under the same conditions as the tripeptide library 
during the generation of AgNPs. Thus, the beads were incubated with AgNO3 solution, washed 
with nanopure water followed by incubation in a solution of sodium ascorbate. Visual inspection 
of the beads under a light microscope revealed that the beads bearing the His/His motive (2a and 
2b) had turned dark red, those with the His/Asp motive (3a and 3b) were dark orange and the 
Ser/Tyr beads (4a and 4b) were yellow, thereby confirming the combinatorial screening results 
(Figure 46). The nature of the linker did not affect the colouration in either bead bound peptide 
sequence, thus we reasoned that it plays no significant role in the formation of AgNPs.
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  a)     b)            c)
   
 
 
His/His-resin 
2a or 2b
50-200 nm      
His/His-resin 
3a or 3b 
50-200 nm     
Ser/Tyr-resin 
4a or 4b 
≤10 nm	
  
Figure 46: Light microscopic (top row) and SEM pictures (bottom row) for AgNPs generated by 
peptide sequences 2 (a), 3 (b) and 4 (c)
SEM analyses of the bead-bound AgNPs showed that the red or dark orange colour from the His/
His or His/Asp peptides corresponds to NPs with an average diameter of approximately  50 nm 
that can agglomerate to larger assemblies of up to 200 nm (Figure 23). Contrastingly, the yellow 
coloured beads from the Ser/Tyr peptide reveal AgNPs which are significantly smaller, with an 
average diameter of approximately  10 nm (Figure 23). These results demonstrate that different 
peptides induce the selective formation of AgNPs of different sizes on bead.
Uptake of Ag+-ions by  different  peptides on beads was calculated by measuring the remaining Ag
+-ion concentration after Ag+-ions are complexed by immobilized peptides (Table 4). Atomic 
Absorption Spectroscopy  (AAS) was used in the Ag+-ion uptake studies. Such studies on the 
uptake of Ag+-ion can also give information on the Ag+-ion affinity of the different peptides with 
reference to earlier studies which were done by Conza with the Wennemers group.12 
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Peptide Bead colour AgNP size mM Ag/mM peptide
2a Dark red 50-200 nm 0.38
2b Dark red 50-200 nm 0.64
3a Dark orange 50-200 nm 0.55
3c Dark orange 50-200 nm 0.47
4a Yellow ≤10 nm 0.26
4b Yellow ≤10 nm 0.19
Table 4: Ag+-ion uptake by peptides bound on Tentagel resin
Differences in the colour of beads correlate with the amount of Ag+-ions that are complexed by 
peptides 2a-4b, as shown in Ag+-ion uptake studies. A more intense colorcolour of the AgNPs on 
the beads, indicates that  the more Ag+ ions is are bound to the immobilized peptide (Table 4). The 
uptake measurements show a significant Ag+-ion affinity for the sequences containing His amino 
acid. Except 2a, peptide sequences containing His/His moieties have the highest Ag+-ion affinity, 
followed by His/Asp sequence. Repeats of experiments on Ag+-ion uptake by  peptide 2a did not 
result in a significant  change of the result. It is not clear why  this peptide gives Ag+-ion uptake 
results which differ from other His/His peptides.
Lowest Ag+-ion affinities were recorded for Ser/Tyr peptide sequences. These results correlate 
with previous studies which showed peptides containing His moieties having higher Ag+ ion 
affinity among different amino acids in various peptides.1 These findings are in close agreement 
with earlier studies which showed the general tendency  of silver preferring coordination with N- 
donor group compared to O- groups.13
Studies were also done to investigate if the Tyr is was able to reduce Ag+-ions and form AgNPs 
without the addition of sodium ascorbate which is the reducing agent for Ag+-ions. After 
incubating beads bearing peptides 4a and 4b with AgNO3, the beads remained colourless. Hence, 
under these conditions Tyr is unable to reduce Ag+-ions.
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4.5 Do the Free N-termini on Immobilized Peptides 2c-4c Influence the Formation of 
AgNPs ?
During the design and synthesis of library 1, the peptides were acetylated at their N-termini to 
avoid unselectively  binding of Ag+-ions to all peptide library members since Ag+ is known to 
complex with N-donor groups.13 Furthermore Banerjee et al. reported the participation of 
peptides’ free amine groups (-NH2) in capping AgNPs and stabilized the nanoparticles to prevent 
them from aggregation.14 Similar findings were published earlier by Reimer et al. who reported 
the interaction between the lone pair of electrons of on the free amine group (-NH2) with the 
vacant orbitals of Ag in their its neutral state.15 In this regard we wanted to investigate if the free 
N-termini on immobilized peptides could have an influence in the generation of AgNPs in 
solution. Peptides 2c (His/His), 3c (His/Asp) and 4c (Ser/Tyr) were prepared for this investigation 
(Figure 47). Since the linker was found to play an insignificant role in the formation of AgNPs, 
only the flexible linker Ahx was chosen to connect the active amino acids in the peptides.
   
  2c       3c  
   
     4c  
Figure 47: Structure of peptides 2c (His/His), 3c (His/Asp) and 4c (Ser/Tyr) used for the AgNP 
formation on Tentagel solid support
In the generation of AgNPs, peptides 2c, 3c and 4c were treated under the same conditions as the 
combinatorial screening library. Similarly, the colour of AgNPs on solid supported peptides was 
visualized under the light microscope (Figure 48 top). In all cases, the heterogeneity of the colour 
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of AgNPs on solid bound peptides shows that the -NH2 group  influences the generation of 
AgNPs.  Efforts to address the inhomogeneity of the colour on beads were fruitless.
  a)     b)     c)
  
  
 
His/His-resin
2c
10 - 70 nm    
His/Asp-resin
3c
10-70 nm   
Ser/Tyr-resin
4c
≤ 50 nm
Figure 48: Light microscopic (top) and SEM  pictures (bottom) for AgNPs generated in the 
presence of peptide sequences 2c (a), 3c (b) and 4c (c)
SEM pictures reveal the highly polydisperse AgNPs on the surface of beads (Figure 48, bottom 
row). AgNPs generated in the presence of His/His 2c and His/Asp  3c were on average smaller 
than their acetylated counterparts, 2a and 3a respectively. The -NH2 group on peptides 2c and 3c 
may  have controlled the size of AgNPs and prevented aggregation of the nanoparticles to sizes of 
up to 200 nm as observed in the presence of the acetylated peptides 2a and 3a.  However, the 
formation of the nanoparticles was poorly controlled by the -NH2 group which is indicated by the 
highly polydisperse AgNPs. 
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Contrary  to this, the Ser/Tyr 4c peptide generates bigger nanoparticles as compared to the 
acetylated form, 4a. The -NH2 group could increase binding affinity of peptide 4c to Ag+-ions 
leading to more and bigger AgNPs being generated after the reduction process.  
Overall, SEM analyses of AgNPs on immobilized N-termini peptides also show the general trend 
in the sizes of AgNPs generated with different sequences (His/His or His/Asp  > Ser/Tyr) 
regarding their acetylated counterparts on (Figure 46).
AgNPs formed on beads bearing resynthesized Ac-/NH2-peptides proved to be stable for several 
months without any change. 
4.6 Ag-Nanoparticle Formation by Peptides 2d-4e in Solution Phase
Having successfully used different peptides to generate different  sizes of AgNPs on solid support, 
we were also interested in finding out if the same trend could be achieved in solution. Moreover, 
many applications of AgNPs take place in solution, hence the need to investigate if our peptides 
could also induce the formation of AgNPs in solution which could later be tested for other 
applications like antibacterial action. 
Peptide sequences 2d-4e (which are similar to their solid supported counterparts), were prepared 
on Rink amide resin (Figure 49). The syntheses were accomplished following the general 
procedure for solid phase peptide synthesis (Experimental section).
Unlike the generation of AgNPs on solid support, solution phase experiments in the presence of 
peptides 2d-4e proved to be more challenging since AgNPs were aggregating during their 
formation. However, through careful adjustment of experimental conditions like pH, ratios of 
peptide/Ag+ and Ag+/sodium ascorbate led to the generation of AgNPs with stabilities 
comparable to AgNPs on bead. For the first  experiments, an excess of the peptides (10 equiv.) in 
comparison to silver nitrate was used for mimicking the excess found on bead. As for the 
generation of AgNPs on bead, sodium ascorbate was used as the reducing agent. The generation 
and the stability of the AgNPs were followed by UV-Visible spectroscopy, the aggregation of 
AgNPs being linked to the enlargement of the peaks with a decrease of their intensity over time. 
The size of the AgNPs was determined using TEM and in all cases the TEM  pictures reported in 
this thesis are of scale bar 40 nm. 
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   2d      2e
  
   3d      3e
  
   4d      4e
Figure 49: Structures of peptides 2d-4e used for the AgNP formation in solution
The first experiments did not show any  evidence of AgNP formation. Since PEG is predominant 
on Tentagel beads used as solid support  for the immobilized peptides, we carried out experiments 
in the presence of varying amounts of PEG to act as an external stabilizer of AgNPs. The UV-
spectra showed the broadening of the SPR peaks with a decrease of their intensity  within a few 
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minutes, for example around 10 minutes. Transmission Electron Microscopy (TEM) analyses of 
the AgNP solutions showed aggregates of nano-and micro-particles.
Godet et  al. reported sodium dodecyl sulfate (SDS) to be a capping agent for AgNPs to prevent 
them from aggregation during their formation.16 After the use of SDS in the presence of our 
peptides similar results when PEG was used were observed. SDS could not prevent the 
aggregation of AgNPs during their formation and this could be due to different reaction 
conditions from those reported.16 Godet et al. used SDS as a AgNP stabilizer but sodium citrate 
and hydrazine hydrate were used as reducing agents. Fortunately, after several trials, through 
careful adjustment of experimental conditions we found conditions that solved the challenge of 
AgNP instability and formation control. Herein, we demonstrate how careful adjustments of the 
experimental conditions allowed for the formation of highly stable AgNPs in solution.
4.6.1 Influence of pH on the Generation of AgNPs
Since the ionic state of each peptide is crucial for their properties, the generation of AgNPs was 
carried out in acidic and basic conditions (pH; 3, 10 and 12).17 As mentioned in section 4.6, the 
first experiments involved the use of an excess of the peptides (10 equiv.) compared to silver 
nitrate to mimick the excess found on-bead. In addition, sodium ascorbate (1.2 equiv. in all 
reported cases of AgNP synthesis) was used as the Ag+-ion reducing agent.
 His/His Peptide Sequence 2d
In the presence of peptide 2d, AgNPs did not form at any of the tested pHs. An explanation could 
be the strong binding affinity of His/His peptide residues to Ag+ as discussed in Chapter 4.4 and 
4.6.3. To overcome this a stronger reducing agent like NaBH4 could reduce Ag+-ions to form 
AgNPs. The use of NaBH4 to reduce Ag+-ions in the presence of a His rich peptide Ala-His-His-
Ala-His-His-Ala-Ala-Asp, was reported by Wright et al.18 
 His/Asp Peptide Sequence 3d
At pH 3, a slight formation of AgNPs was found in the presence of peptide 3d with the apparition 
of a broad peak after 2 h (Figure 50). TEM  analyses revealed the formation of large and 
heterogeneous aggregates of up to 500 nm in diameter. The modest formation of AgNPs that 
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aggregate at pH 3 might have been due to poor coordination of the peptide on the AgNPs. At this 
acidic pH, the amino acids His/Asp in peptide 3d are in their protonated states (pKa; Hisimidazole ≈ 
6 and Asp-COOH ≈ 4). Therefore the imidazole as well as the carboxylic moieties bore by  the 
peptide 3d might not efficiently bind to AgNPs to enhance their stability.
Figure 50: a) UV-Vis spectra after 10 min (black curve) and 2 hours (red curve) and b) TEM 
pictures (scale bar 40 nm) of the AgNPs solution generated in the presence of Ac-His-Ahx-Asp-
NH2 3d (10 equiv.)
Peptide 3d at pH 10 gives AgNPs with a sharp and intense plasmon resonance band after 2 h with 
a maximum at a wavelength around 405 nm (Figure 27a). At pH 10 peptide 3d generates AgNPs 
in defined size with an average diameter of 20 nm (Figure 50b). Peptide 3d contains free 
carboxylate and imidazole groups which could influence the generation of defined size of AgNPs 
and stabilise the nanoparticles against aggregation at pH 10. Studies by Wright et al. reported that 
the carboxylate and imidazole groups of peptide Ala-His-His-Ala-His-His-Ala-Ala-Asp 
interacted with Ag0 which led to the formation of stable AgNPs at pH 8.6.18 Recently, Wang et al. 
also reported that a polypeptide containing aspartate and imidazole groups led to the formation of 
stabilised AgNPs.19 We therefore infer that the presence of negatively charged carboxylate groups 
and neutral imidazole on peptide 3d has a higher affinity  for coordination to AgNPs resulting in 
their controlled growth and stability. 
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AgNPs generated in the presence of peptide 3d at pH 12, are associated with a less intense double 
SPR peak which both Mirkin et al.20 and Xie et  al.9 attributed this to AgNPs not having a 
spherical shape (Figure 50). Interestingly, the size and the shape of the AgNPs synthesized in the 
presence of peptide 3d are significantly different at pH 10 and pH 12. Compared with the small 
uniform nanoparticles produced at pH 10, larger nanoparticles with an average size of 40 nm with 
different shapes, such as triangles or hexagons, were produced at pH 12 (Figure 50). These results 
suggest that at pH 12 the Ag+ ions are bound tighter to the peptide in comparison to pH 10. This 
tighter binding at pH 12 could mean that less Ag+-ions are available at  the initiation of the 
reduction, hence fewer nuclei are formed, resulting in bigger AgNPs. 
Our findings regarding the smaller size of AgNPs generated at  pH 10 and bigger size of 
nanoparticles generated at  pH 12, could be compared to the data by Sharma et al.21 The authors 
synthesised AgNPs by the tollens method in the presence of sugars (glucose, galactose, maltose 
or lactose. They found that an increase in pH (11.5 to 13.0) led to a relative increase in the size of 
AgNPs during their generation. Sharma et al reported that an increase in pH resulted in a decrease 
in free Ag+-ions in solution and following reduction of these ions, Ag nuclei were formed which 
grew to larger AgNPs.21
Therefore, our AgNP results achieved in the presence of peptide 3d could indicate that  the 
peptide is acting as a reservoir of Ag+ ions, releasing them slowly  into the media for the growth 
process and this explains the slow growth of AgNPs at  pH 12 in comparison to pH 10 (Figure 
50). On the another hand, the binding of peptide 3d to the AgNPs could allow a preferential 
addition of Ag0 atoms onto the AgNPs controlling their shape, giving triangles and hexagons at 
pH 12. 
Our results could also be explained by the findings of Wright et al. when they used peptide Ala-
His-His-Ala-His-His-Ala-Ala-Asp in the generation of AgNPs.18 After carrying out infrared 
analysis of the purified AgNPs, they found that the pattern of vibrational stretching frequencies 
revealed AgNP-carboxylate interactions. Furthermore, the histidine analogues on their peptide 
were found to display  a loss of N-H bands implying the imidazole binding to AgNPs. From their 
results Wright et al. concluded that the peptide ligand interacts with Ag+-ions to form a ligand-
stabilized precursor complex. Upon addition of reductant, small nuclei were reported to form 
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rapidly. The peptide would then adhere to growing Ag nuclei which results in lower surface 
energy on the bound faces leading to biased deposition of Ag nuclei on the unbound faces.18 The 
biased addition of Ag nuclei onto the nanoparticle could then explain the different shapes of 
AgNPs we obtained.
 Ser/Tyr Peptide Sequence 4d
In a fashion similar to that observed with peptide 3d at pH 3, TEM analyses revealed the 
formation of large heterogeneous aggregates of up  to 500 nm in diameter (Figure 51). These 
aggregates of AgNPs formed at pH 3 could be a result of poor coordination of the peptide 4d on 
the AgNPs, a requirement for AgNP stability. At pH 3 amino acids Ser/Tyr in peptide 4d are in 
their neutral states, consequently  the tyrosine residue, in its phenol form, is not able to bind 
tightly to the AgNPs. However, even at pH 10 peptide 4d does not induce the formation of 
individual silver nanoparticles, instead aggregates are formed like at pH 3 indicated by a broad 
peak in the UV-Vis spectrum. This was confirmed by TEM analyses (Figure 51). The AgNP 
aggregates could reveal that there is still less stabilization of the growing nanoparticles since the 
Tyr residue in peptide 4d is only partially deprotonated whereas the Ser is neutral at pH 10.
Interestingly, at pH 12 in the presence of peptide 4d, nanoparticles which are formed are small 
and disjointed (15 nm average size) highlighted by a sharp and intense plasmon resonance band 
(maximum at 410 nm) in UV-Vis spectroscopy and confirmed by  TEM (Figure 51). Above pH 
11, the Tyr residues of peptide 4d are deprotonated (pKa≈10) and are available for forming 
peptide-AgNPs interactions as evidenced by the formation of individual AgNPs. The reduction 
and the AgNPs growth processes are faster than the ones observed for peptide 3d which could be 
a result  of the combined effect  of Ag+ ions reduction by Tyr9,10 along with sodium ascorbate 
activity. Furthermore, AgNPs generated in the presence of peptide 4d show a larger size 
distribution perhaps due to the peptide being a weaker binder of Ag+ than peptide 3d. This lower 
affinity would result in both nucleation and the growth processes taking place simultaneously  and 
this could then explain the slightly polydispersed 4d-AgNPs.
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Figure 51: a) UV-Vis spectra after 10 min (black curve) and 2 hours (red curve) and b) TEM 
pictures (scale bar = 40 nm) of the AgNPs solution generated in the presence of Ac-Ser-Ahx-Tyr-
NH2 4d (20 equiv.)
 Investigation of Ag2O by Xray Photoemission Spectroscopy
Xray Photoemission Spectroscopy (XPS) analysis did not show any evidence of silver oxide 
formation during the generation of AgNPs. Silver oxide can affect  the shape of the nanoparticles 
that the peptides induce. This could result in the formation of poorly defined shapes of AgNPs. 
Therefore XPS analysis of AgNPs was carried out to learn more about the behaviour of silver on 
the surface and during the reduction process. This measurement reveals the chemical 
environment and the oxidation state of silver in different reduced and non-reduced samples. 
Figure 52 shows the XPS spectrum of the Ag 3d region for 3d- and 4d-AgNPs. Two silver bands 
centred at binding energies of 367.6 and 373.6 eV, are typical for Ag0 and can be assigned to the 
3d5/2 and 3d3/2 Ag peaks respectively.22 Anantharaman and coworkers reported the binding energy 
of silver oxide to be around 366 eV. 22  
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   a)       b)  
   
Figure 52: XPS spectra for 3d-AgNPs (a) and 4d-AgNPs (b) generated at pH 12. 
4.6.2 Influence of Peptide Concentration on the Generation of AgNPs
After determining the optimum pH for the generation of AgNPs for each peptide, several 
experiments with different ratios of peptide to Ag+ were carried out to investigate the influence of 
the peptide on the stability  of AgNPs. We chose to use both pH 10 and 12 for the experiment with 
peptide 3d since two different  sizes of AgNPs were found earlier. Generations of AgNPs with 
different quantities of peptide 4d were performed at the optimized pH 12. The effect of 
concentration of the peptide in the formation of AgNPs was monitored by measuring the UV-Vis 
spectra of the AgNP solution media at different  time intervals. Size characterisation of AgNPs 
was determined by  TEM analyses of the nanoparticle solution dried on carbon-coated copper 
grids.
 His/Asp Peptide Sequence 3d
The growth rate of AgNPs at pH 10 and pH 12 was followed over a period of one hour when the 
growth of AgNPs terminated for peptide/Ag+ ratio of 1 in the presence of peptide 3d (Figure 53 
and 54). The nature of the normalised absorbance curves calculated from the UV-Vis absorbance 
spectra of AgNPs as a function of time indicates that the rate of AgNP formation decreases with 
an increase of the peptide/Ag+ ratio from 1:1 to 20:1 at pH 10 and pH 12 (Figures 53 and 54).
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Figure 53: Normalised absorbance curves of AgNPs generated in the presence of 3d/Ag+ ratios of 
1:1 (at λ = 402 nm), 5:1 (at λ = 404 nm), 10:1 (at λ = 406 nm) and 20:1 (at λ = 418 nm) at pH 10
We reported (Chapter 4.6.1) that peptide 3d could be acting as a reservoir of Ag+ ions, releasing 
them slowly into the media for the growth of AgNPs. Therefore, we speculate that an increase of 
peptide/Ag+ ratio (from 1:1 to 5:1, 10:1 and 20:1) leads to more Ag+ ions being complexed on the 
peptide resulting in a lower concentration of free Ag+-ions in solution to be reduced to form 
AgNPs. This slows the growth rate of AgNPs as observed in Figure 53 and 54. Furthermore, the 
decrease in the rate of AgNP formation with an increase of the peptide/Ag+ ratio (from 1:1 to 5:1, 
10:1 and 20:1) could indicate that peptide 3d’s major impact is on AgNP growth. Moreover, it has 
been observed by Vaia et al. that an increase in the concentration of peptide leads to a decrease in 
the rate of nanoparticle growth.23 Such a role of peptide on AgNP formation takes place if the 
peptide’s major impact is on the nanoparticle growth due to the passivation of the surface of 
nanoparticles.23
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Figure 54: Normalised absorbance curves of AgNPs generated in the presence of 3d/Ag+ ratios of 
1:1 (at λ = 409 nm), 5:1 (at λ = 428 nm), 10:1 (at λ = 432 nm) and 20:1 (at λ = 445 nm) at pH 12 
At pH 10 non-aggregated AgNPs were formed in the presence of peptide 3d when the peptide/Ag
+ ratio was greater than 1 (Figure 55). An increase in the size of AgNPs is correlated with an 
increase in the 3d/Ag+ ratio from 1:1 to 20:1. Highly stable (for at least 3 months) and uniform 
size AgNPs were achieved when the ratio of 3d/Ag+ was between 5:1 and 10:1. At lower peptide 
3d/Ag+ ratios (ratio = 1:1), the nanoparticles exist in form of aggregates at  pH 10 revealing that 
there is inadequate peptide in solution to stabilise the AgNPs (Figure 55). A further increase in 
the 3d/Ag+ ratio to 20:1 resulted in the aggregation of AgNPs over time (3 months) which can be 
confirmed by UV-Vis spectra (Figure 55). The aggregation of AgNPs was also confirmed by 
TEM  analysis (Figure 55). In addition, the nanoparticles which were generated at  a 3d/Ag+ ratio 
of 20:1 are on average larger than the nanoparticles which are generated at lower 3d/Ag+ ratios. 
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Figure 55: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of different peptide/Ag+ ratios at pH 10 (results presented were taken at 3 months)
Similarly, at pH 12 the average size of the AgNPs increases with an increase in the 3d/Ag+ ratio 
(from 1:1 to 5:1, 10:1 and 20:1) as shown in Figure 56.
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Figure 56: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of different peptide/Ag+ ratios at pH 12 (results presented are taken at 3 months)
 An increase in the concentration of peptide 3d could lead to more peptide-Ag+-ions adsorbing on 
the surface of growing nanoparticles resulting in the corresponding increase in nanoparticle size. 
Furthermore, an increase in the 3d/Ag+ ratio (from 1:1 to 5:1, 10:1 and 20:1) could enhance 
preferential binding of the peptide on certain faces of nanoparticles. The surface energy of the 
faces of AgNPs where the peptides bind are lowered thereby biasing the addition of Ag-atoms on 
unbound faces, which could explain the formation of different shapes of AgNPs such as triangles 
or hexagons at pH 12. Overall AgNPs synthesised at different peptide/Ag+ ratios were also stable 
for at least three months (Figure 56).
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 Ser/Tyr Peptide Sequence 4d
Unlike the results achieved in the presence of peptide 3d, an increase of peptide/Ag+ ratio (from 
1:1 to 5:1, 10:1 and 20:1) leads to an increase in the growth rate of AgNPs in the presence of 
peptide 4d (Figure 57). These results could indicate that unlike peptide 3d whose major influence 
could be on the growth of AgNPs, the major impact of peptide 4d could be in the nucleation 
process. Vaia and coworkers reported similar findings.23 The pronounced decrease in the 
absorbance of AgNPs generated in the presence of 4d/Ag+ ratios of 1:1 and 5:1 could be due to 
the change of nanoparticle size in the solution over time (Figure 58).
  
Figure 57: Normalised absorbances (at λ = 409 nm) of AgNPs generated at pH 12 in the presence 
of 4d/Ag+ ratios of 1:1, 5:1, 10:1 and 40:1. Growth rate results of AgNPs which are presented 
were taken over a period of an hour when the growth of AgNPs terminated     
In the presence of peptide 4d, AgNPs aggregate at a ratio of peptide/Ag+ of 1:1 (Figure 58) at pH 
12. Figure 58 shows that the UV-Vis spectra become sharper as the 4d/Ag+ ratio increases from 
1:1 to 40:1 favouring the generation of smaller (≤ 15 nm) and nearly monodisperse nanoparticles 
(Figure 58).
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Figure 58: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 4d-AgNPs generated in the 
presence of different peptide/Ag+ ratios at pH 12 (results presented were taken at 3 months)
4.6.3 The Role of the Linker in AgNP Formation
The combinatorial screening studies have shown that the relative orientations of the two amino 
acids in a given peptide might not be crucial for the affinity of the peptides to Ag+/AgNPs 
whereas the nature of the amino acids is responsible for the different size of the AgNPs.2 In order 
to support this finding, we carried out further studies on the formation of AgNPs in solution. 
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The morphology of the AgNPs obtained in the presence of peptides 3e and 4e, which both bear a 
rigid linker are similar to their respective counterparts with a flexible linker, at  the optimized 
conditions (Figure 55). These results further support the finding that the linker does not play  a 
crucial role in the formation of AgNPs, but only  the different  active amino acids in a peptide 
(Figure 59). 
             
Figure 59: UV-Vis spectra and TEM  pictures (scale bar = 40 nm) of AgNPs generated in the 
presence of different linkers of peptides 3d-e and 4d-e at pH 10 and pH 12 respectively (results 
presented were taken at 3 months)
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 Peptide-Ag+ Binding Affinity Studies by Isothermal Titration Calorimetry
Isothermal titration calorimetry (ITC) is a powerful and highly  sensitive technique that is capable 
of measuring the change in the enthalpy upon intermolecular/intramolecular interaction of species 
in solution.24 We have investigated the non-covalent interaction of peptides during titration 
against aqueous AgNO3 to rationalize the observed different behaviour of the different peptides 
during the formation of AgNPs.
  a)    b)    c)
               
Figure 60: ITC titration data describing the interaction of peptide 2d (a), 3d (b) and 4d (c) with 
Ag+-ions at pH 7.5 
The experiment revealed that peptide 2d bearing two His residues binds Ag+ at pH 7.5 with a 
binding ∆G = -8.5 ± 0.06 kcalmol-1 and is the strongest ligand among the peptides tested (Figure 
60 and Table 5). This could explain the observation that when using ascorbate as a reducing agent 
no AgNP were formed in the presence of this peptide. Ag+-ions are probably bound tightly to the 
imidazole moieties of this peptide. Xie and coworkers reported that Ag+ complexation lowers the 
reducibility of Ag+-ions.9 Therefore, the reducibility  of the peptide(Ag+)peptide complex is 
expected to decrease with an increase in the binding strength. In case of Ac-His-Ahx-His-NH2 
2d, the equilibrium lies heavily  to the peptide(Ag+)peptide complex resulting in no Ag+-ions in 
available solution to be reduced to form AgNPs (Scheme 4).
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               Peptide                                 ΔG (kcalmol-1)
Ac-His-Ahx-His-NH2 2d                 -8.5 ± 0.06
Ac-His-Ahx-Asp-NH2 3d                 -5.5 ± 0.12
Ac-Ser-Ahx-Tyr-NH2 4d                  -4.2 ± 0.34
Table 5: Binding affinities of peptides 2d, 3d and 4d to Ag+-ions
In addition, the ITC measurements indicate stronger binding of peptide 3d (∆G = -5.5 ± 0.12 
kcalmol-1) with Ag+-ions whereas the interaction is weaker for peptide 4d (∆G = -4.2 ± 0.34 
kcalmol-1) under identical conditions. For peptide 2d the observed binding affinity  is a result of 
the combined non-covalent interactions of the two imidazole residues (pKa His (imidazole) ≈ 6) 
with Ag+-ions. At pH 7.5 the imidazole and the aspartic acid (pKa Asp (-COOH) ≈ 4) residues in 
peptide 3d could be both contributing to non-covalent interactions with Ag+-ions. For peptide 4d 
containing amino acids tyrosine (pKa ≈ 10) and serine (pKa ≈ 13), at  pH 7.5 the observed binding 
affinity (∆G = -4.2 ± 0.34 kcalmol-1) could be mainly  from the Ag+-ions interacting with tyrosine 
‘s π-electron system.
 
Scheme 4: General outline of a peptide-Ag+ complex
4.6.4 Could the free N-termini on Peptides Influence the Formation of AgNPs in Solution?
Similarly, studies were carried out to investigate the influence of the terminal NH2-group of 
peptides 2f, 3f and 4f on the formation of AgNPs (Figure 61).
Peptides 2f (NH2-His-Ahx-His-NH2), 3f (NH2-His-Ahx-Asp-NH2) and 4f (NH2-Ser-Ahx-Tyr-
NH2) were used as additives under identical conditions to those used with their acetylated forms 
during the generation of AgNPs. For comparison, only pH 10 was considered and used for 
peptide 2f and 3f while pH 12 was used for peptide 4f.
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After mixing peptide 2f with AgNO3 and subsequent addition of sodium ascorbate, the mixture 
remained colourless. The extra -NH2 group did not improve the problems on the formation of 
AgNPs in the presence of the peptide NH2-His-Ahx-His-NH2 2f.
 
   2f       3f
    
       4f
Figure 61: Structures of peptides 2f, 3f and 4f which were used in AgNP formation
Interestingly, in the presence of the His and Asp  residue bearing peptide 3f highly stable (for at 
least 3 months) AgNPs were generated. Comparing the 2 h UV spectra (Figure 62a-b) of 3f- and 
3d-AgNPs, the -NH2 group led to lower SPR absorbance of AgNPs. This was expected since the -
NH2 group is an extra binder of silver that  could result a reduction in number of unbound Ag+-
ions in solution compared with peptide 3d whose N-terminus is acetylated. In addition, the -NH2 
group could be repelling the nanoparticles from each other resulting in their enhanced stability 
over time.
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   a)       b)
Figure 62: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for 3f-AgNPs (a) and 3d-
AgNPs (b) generated at pH 10, (results presented were taken at 3 months)
The broad UV spectra (Figure 63a) as well as the TEM results indicate that peptide NH2-Ser-
Ahx-Tyr-NH2 4f generates highly polydispersed and aggregates of AgNPs. The TEM images 
implies that the use of peptide NH2-Ser-Ahx-Tyr-NH2 4f as an additive generates bigger size of 
AgNPs than the nanoparticles synthesised in the presence of peptide Ac-Ser-Ahx-Tyr-NH2 4d 
(Figure 63b). The bigger size of AgNPs which are generated could mean that peptide 4f is a 
stronger binder (from the -NH2 group) of silver than its acetylated form Ac-Ser-Ahx-Tyr-NH2 4d 
that generates smaller AgNPs.
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   a)       b)
Figure 63: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for 4f-AgNPs (a) and 4d-
AgNPs (b) at pH 12 (results presented were taken at 5 h)
4.6.5 The Generation of AgNPs Without Sodium Ascorbate 
Studies were carried out investigating the formation of AgNPs in the presence of our peptides but 
without inclusion of the reducing agent, sodium ascorbate. The aim was to explore a new method 
of utilising peptides 3d and 4d in reducing Ag+-ions to Ag0 that could lead to the formation of 
defined size and shape of AgNPs. A few publications have reported that peptides bearing non Ag+ 
reducing amino acid residues like tyrosine or tryptophane are able to reduce Ag+ to Ag0 leading to 
the formation of AgNPs.9,10 Most  of the reported findings emphasise the need for carboxyl groups 
like aspartate or glutamate which supply  electrons to reduce Ag+ to Ag0.25,26 Belcher et al. used 
hexaglutamic acid and hexaaspartic acid in the synthesis of AgNPs at room temperature without a 
reducing agent.25 They found that silver ions bound to carboxyl groups were easily  reduced even 
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at ambient light.25 In another study Aroca et  al. generated AgNPs in the presence of amino acids 
glycine, cysteine and lysine as in situ reducing agents for Ag+ to Ag0 under boiling conditions.26 
Despite extensive research, the control of size and shape of AgNPs is still a great challenge in the 
generation of AgNPs using peptides as Ag+-ion reducing agents. Therefore, we speculated that 
the generation of AgNPs in the presence of peptide 3d or 4d could lead to better control of 
nanoparticle size and shape than existing techniques. We carried out studies on generating AgNPs 
without a reducing agent using our optimised reaction conditions. Silver nanoparticle formation 
in the presence of peptide 3d was followed at pH 10 and pH 12 whereas nanoparticle formation 
in the presence peptide 4d were done at pH 12. In all cases a peptide/Ag+ ratio of 5:1 was used.
 The Generation of AgNPs in the Presence of Peptide 3d
Figure 64 show a comparison of the UV-Vis surface plasmon absorption spectra and TEM images 
for AgNPs prepared in the presence and absence of sodium ascorbate which is the Ag+-ion 
reducing agent. Without sodium ascorbate peptide 3d cannot reduce Ag+-ions to induce the 
generation of AgNPs and only aggregates of micro-molecules which could be AgNO3 are 
observed at pH 10.
An increase of pH to 12 led to the formation of AgNPs in the presence of peptide 3d without 
sodium ascorbate as additive (Figure 65). Therefore peptide 3d is able to reduce an Ag+-ion to 
Ag0 leading to the generation of AgNPs at pH 12. TEM  images in Figure 65 show AgNPs in 
similar shapes and average sizes of 40 nm. However, the UV-Vis spectra for AgNPs synthesized 
without sodium ascorbate are typical for nanoparticles with a non-spherical shape.9,20 The 
aspartate group on peptide 3d could be responsible for the reduction of Ag+ which led to the 
formation of AgNPs. Recently, Khan and coworkers reported evidence of the aspartate group 
being responsible for providing electrons to the reduction of Ag+-ions at  pH 11.5. Their evidence 
was derived from spectrophotometric, kinetic, and TEM data that showed the dependence of the 
reduction process on the concentrations of NaOH and aspartate.27
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   a)       b)
  
  
Figure 64: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for 3d-AgNPs generated in the 
presence of sodium ascorbate (a) and without sodium ascorbate (b) at pH 10, (results presented 
were taken after 1 month)
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Figure 65: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for 3d-AgNPs generated in the 
presence of sodium ascorbate (a) and without sodium ascorbate (b) at pH 12
 The Generation of AgNPs in the Presence of Peptide 4d
Peptide 4d as an additive led to the formation of AgNPs in the presence or without sodium 
ascorbate as an additive (Figure 66). Peptide 4d bears a tyrosine residue which is able to reduce 
Ag+ to Ag0 at pH 12.10 TEM images in Figure 66b show that larger (≤ 40 nm) AgNPs were 
generated without sodium ascorbate whereas smaller size (≤ 15 nm) AgNPs were generated in the 
presence of sodium ascorbate as an additive (Figure 66a). Sodium ascorbate could be required to 
promote the formation of smaller size of AgNPs in the presence of peptide 4d as an additive.
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Figure 66: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for 4d-AgNPs generated in the 
presence of sodium ascorbate (a) and without sodium ascorbate (b) at pH 12 (results presented 
were taken at 1 month)
4.6.6 Investigation of the Influence of Dehydroascorbate on the Generation of AgNPs
Efforts to purify our AgNPs through centrifugation or size exclusion chromatography using 
sephadex have not been successful. AgNPs aggregated after the centrifugation process and size 
exclusion chromatography led to the AgNPs sticking on the column resulting in no elution of 
nanoparticles. Studies were then carried out to investigate the influence of dehydroascorbate, the 
oxidised form of sodium ascorbate which is present in the AgNP solution during and after their 
synthesis.
In our investigations, dehydroascorbate/sodium ascorbate ratios of 0:3, 1:2, 2:1 and 3:0 were 
explored in the formation of AgNPs in the presence of peptide 3d or 4d. The optimised 
conditions were used for the generation of AgNPs, which were pH 10 and pH 12 for peptide 3d 
and pH 12 for peptide 4d. The ratio of peptide/Ag+ used in these studies was 5:1.
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 The Generation of AgNPs in the presence of peptide 3d
The UV-Vis spectra and TEM images show that at pH 10 dehydroascorbate by itself facilitates 
the formation of AgNPs (Figure 67 and 68d). Without the reducing agent, sodium ascorbate, the 
source of electrons to reduce Ag+ to Ag0 is unknown and yet to be explored. 
In addition, an increase of the ratio of dehydroascorbate/sodium ascorbate ratio from 0:3 to 1:2, 
2:1 and 3:0 resulted in a general decrease of the size of the AgNPs that were generated (Figure 
67). Furthermore, an increase in the ratio of dehydroascorbate/sodium ascorbate from 0:3 to 1:2, 
2:1 and 3:0 resulted in the generation of polydispersed AgNPs which increased in relation to an 
increase in the concentration of dehydroascorbate. The decrease in the nanoparticle size as well 
as the increase in nanoparticle dispersity relative to an increase in the concentration of 
dehydroascorbate could indicate that dehydroascorbate determines the number of critical nuclei 
during the formation of AgNPs. In this system it  could be that the processes of nucleation and 
growth of AgNPs are taking place simultaneously. Efrima et al. reported that the processes of 
nucleation and growth are critical in the formation of AgNPs.28 Therefore, polydisperse 
nanoparticles are produced if these two processes take place simultaneously.29 In Figure 64, 
peptide 3d at pH 10 could not induce the formation of AgNPs without sodium ascorbate. 
Therefore the TEM  results shown in Figure 68d indicate that dehydroascorbate plays a role in the 
reduction of Ag+-ion to Ag0 in the formation of nanoparticles.
    
Figure 67: UV-Vis spectra of 3d-AgNPs generated in the presence of dehydroascorbate /ascorbate 
ratio of 0:3, 1:2, 2:1 and 3:0 at pH 10 (results presented were taken at  24 h)
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Figure 68: TEM  pictures (scale bar = 40 nm) of 3d-AgNPs generated in the presence of 
dehydroascorbate /ascorbate ratios of 0:3 (b), 1:2 (c), 2:1 (d) and 3:0 (e) at pH 10 (results 
presented were taken at 24 h)
Likewise, the UV-Vis spectra and TEM images show that at pH 12 dehydroascorbate by itself 
leads to the formation of AgNPs (Figure 69 and 70). Previously in Figure 65, peptide 3d without 
a reducing agent  has been shown to induce the formation of AgNPs at pH 12. Therefore, the 
results achieved at pH 12 could be a contribution of peptide 3d and dehydroascorbate. Unlike the 
results at pH 10, the UV-Vis results of AgNPs generated at pH 12 show a clear red shift in the 
spectra relating to an increase in the ratio of dehydroascorbate/sodium ascorbate from 0:3 to 1:2, 
2:1 and 3:0.  
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Figure 69: UV-Vis spectra of 3d-AgNPs generated in the presence of dehydroascorbate /ascorbate 
ratio of 0:3, 1:2, 2:1 and 3:0 at pH 12 (results presented were taken at 24 h)
   a)       b)
  
   c)       d)
  
Figure 70: TEM  pictures (scale bar = 40 nm) of 3d-AgNPs generated in the presence of 
dehydroascorbate /ascorbate ratios of 0:3 (b), 1:2 (c), 2:1 (d) and 3:0 (e) at pH 12 (results 
presented were taken at 24 h)
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In a fashion similar to that observed with peptide 3d at pH 10, UV-Vis and TEM analyses 
revealed that an increase in the ratio of dehydroascorbate/sodium ascorbate from 0:3 to 1:2, 2:1 
and 3:0 resulted in the generation of polydisperse AgNPs at pH 12 (Figure 69 and 70). 
Furthermore the polydisperse of AgNPs increased with respect to an increase in the ratio of 
dehydroascorbate/sodium ascorbate from 0:3 to 1:2, 2:1 and 3:0. The decrease in the nanoparticle 
size as well as the increase in nanoparticle dispersity  relative to an increase in the concentration 
of deydroascorbate could also indicate that deydroascorbate determines the number of critical 
nuclei during the formation of AgNPs. In this system at pH 12 the processes of nucleation and 
growth of AgNPs could be taking place simultaneously.
Overall, these studies have shown that dehydroascorbate influences the size dispersity of AgNPs 
during their generation especially at  pH 12, this could explain the wide size variation of AgNPs 
generated at pH 12 in Figure 56.  
 The Generation of AgNPs in the presence of peptide 4d
The UV-Vis spectra shown in Figure 71 also indicate that there is AgNP formation in the 
presence of dehydroascorbate at pH 12. In this system the influence of dehydroascorbate is 
unclear, given that without a reducing agent such as sodium ascorbate, the tyrosine moiety in 
peptide 4d is able to reduce Ag+ to Ag0 to form AgNPs at pH 12 (Figure 72).
   
Figure 71: UV-Vis spectra of 4d-AgNPs generated in the presence of dehydroascorbate /ascorbate 
ratios of 0:3, 1:2, 2:1 and 3:0 at pH 12 (results presented were taken at 24 h)
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Figure 72: TEM  pictures (scale bar = 40 nm) of 4d-AgNPs generated in the presence of 
dehydroascorbate /ascorbate ratio of 0:3 (b), 1:2 (c), 2:1 (d) and 3:0 (e) at pH 12 (results 
presented were taken at 24 h)
An increase of the ratio of dehydroascorbate/sodium ascorbate ratio from 0:3 to 1:2 also favours 
the formation of smaller size of AgNPs (Figure 72). Unlike the studies which were carried out in 
the presence of peptide 3d, increments of dehydroascorbate/sodium ascorbate ratio to 2:1 and 3:0 
did not lead to a significant change	
   in the size of the resulting AgNPs in the presence of peptide 
4d. These results imply  that peptides 3d and 4d interact differently  with AgNPs in the presence of 
dehydroascorbate and sodium ascorbate leading to the observed variation in nanoparticle size. 
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4.6.7 The Generation of AgNPs in the Presence of Inorganic Salts
We could successfully generate AgNPs in different sizes in the presence of different peptides, 
however the generation of homogeneously defined shapes of AgNPs is yet to be achieved. Kitaev 
and coworkers have discovered that addition of inorganic salts like chlorides and bromides could 
control the shape of AgNPs by the coordination of these halides to the active facets of the 
nanoparticles during their formation.30 Halides are presumed to help in coordinating to silver 
nuclei, thereby  stabilizing them against aggregation.31 Stabilization against aggregation could 
result in the generation of defined shapes of AgNPs.30
Bearing these results in mind, we explored the use of peptides 3d and 4d in the generation of 
AgNPs in the presence of potassium chloride (KCl), potassium bromide (KBr), sodium chloride 
(NaCl) and sodium bromide (NaBr). With the generation of AgNPs carried out at the optimized 
conditions, that is at pH 10 and pH 12 for peptide 3d whereas the pH was 12 for 4d. Ratios of 
halide/Ag+ of 0.24 and 1 will be illustrated to show the influence of halides in the formation of 
AgNPs in the presence of peptides 3d and 4d as additives at pH 12.
	
   Generation of AgNPs in the Presence of Peptide 3d and Halides
AgNPs which were generated in the presence of peptide 3d and KCl show a typical SPR band 
which is centered at 405 nm (Figure 51). The TEM  image on Figure 51a shows monodisperse 
AgNPs of average size of 20 nm.
It was surprising to observe a few nanorods of average length of 30 nm. When the ratio of KCl/
Ag+ was increase to 1, the nanorods were found to increase in length to about 60 nm as well as 
increase in quantity (Figure 73). Beyond the KCl/Ag+ ratio of 1, the nanoparticle solution turned 
faint white accompanied by a slow formation of AgNPs. The white colouration could be the 
formation of AgCl. The decrease in the ratio of KCl/Ag+ from 0.24 resulted in no significant 
effect to the generation of AgNPs. These results show that KCl contributes to the formation of 
Ag-nanorods since experiments in absence of KCl did not reveal the formation of nanorods.
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   a)       b)
  
  
   
3d-AgNPs 
≤ 20 nm     
3d-AgNPs 
≤ 60 nm
Figure 73: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of KCl/Ag+ ratio of 0.24 (a) and KCl/Ag+ ratio of 1 (b) at pH 10
In order to evaluate the influence of other halides in the generation of AgNPs, experiments were 
carried out in the presence of KBr, NaBr and NaCl in a ratio of halide/Ag+ of 0.24. Figure 74 
showed no significant influence of these halides in the formation of AgNPs in the presence of 
peptide 3d at pH 10. The observed differences in the UV-Vis spectra as well as nanoparticle size 
in Figure 52a-c could be a result of the influence of the cation (Na+- or K+-ion) in the formation 
of AgNPs.
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Figure 74: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of KBr (a), NaBr (b) and NaCl (c) in a ratio of halide/Ag+ of 0.24 at pH 10
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Figure 75 also shows that peptide 3d can induce the formation of AgNPs at pH 12 in the presence 
of KCl. TEM studies confirm the formation of AgNPs which also look like nanorods. 
Future studies using a high resolution TEM that has a tiltable specimen stage could reveal the 
actual shapes of AgNPs.
   a)       b)
  
  
   
3d-AgNPs 
≤ 50 nm     
3d-AgNPs 
aggregates
Figure 75: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of KCl/Ag+ ratio of (a) 0.24 and (b) 1 at pH 12
Unlike the observations at pH 10, when the ratio of KCl/Ag+ was increased to 1, the nanoparticle 
solution turned faint white accompanied by aggregation of AgNPs (Figure 75b). Similarly, a 
decrease in the ratio of KCl/Ag+ from 0.24 resulted in no significant effect to the generation of 
AgNPs. AgNPs which were generated in the presence of peptide 3d and KCl show a SPR band 
which is centered at 450 nm (Figure 75).
Overall the generation of AgNPs at pH 12 in the presence of 3d and halides such as KBr, NaBr 
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and NaCl in a ratio of halide/Ag+ of 0.24 led to formation of AgNP aggregates (Figure 76).
   a)       b)
  
  
   c)  
    
Figure 76: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 3d-AgNPs generated in the 
presence of KBr (a), NaBr (b) and NaCl (c) in a ratio of halide/Ag+ of 0.24 at pH 12
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The UV and TEM studies of AgNP formation in the presence of peptide 4d and halide KCl, KBr, 
NaCl or NaBr indicate that  halides do not play a significant influence in the synthesis of AgNPs 
(Figure 77 and 78). Even after the increase or decrease of the halide/Ag+ ratio, the observations 
did not change. This was a surprising result  since one would expect  to observe similar effects to 
those observed for peptide 3d, especially on increasing the halide/Ag+ ratio from 0.24 and above. 
Above this ratio of 0.24, the nanoparticle solution could show the formation of AgCl or AgBr, a 
white precipitate. One explanation could be that the combination of peptide 3d and 4d with 
halide leads to different interactions with crystallographic facets of AgNPs.32 These different 
interactions can lead to the anisotropic growth of AgNPs which result in the observed nanorods 
for 3d or no effect regarding peptide 4d. 
   a)       b)
  
  
Figure 77: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 4d-AgNPs generated in the 
presence of KCl (a), KBr (b) in a ratio of halide/Ag+ of 0.24 at pH 12
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Figure 78: UV-Vis spectra and TEM pictures (scale bar = 40 nm) of 4d-AgNPs generated in the 
presence of NaCl (a), NaBr (b) in a ratio of halide/Ag+ of 0.24 at pH 12
Figure 79 illustrates the general mechanism for the formation of different shapes of AgNPs from 
Ag-nuclei.33 Tsuji et al. proposed that different shapes of AgNPs evolved from various face 
centred cubic Ag nanoprecusors (Table 6 and Figure 79). 
Initial shape of AgNP Final shape of AgNP
small multiple-twinned sphere nanosphere
decahedron nanorod or nanowire
cubo-octahedron cube
triangular and hexagonal nanoplate triangular bi-pyramid and 1-D nanoplate
Table 6: Ininital and final shapes of AgNPs as proposed by Tsuji et al33
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Figure 79: Mechanism of shape selective oxidative etching and crystal growth of Ag-
nanostructures33
Moreover, for biological applications, AgNPs should display high stability in high ionic strength 
environments. Studies that  were done on the formation of AgNPs on the presence of especially 
KCl show that 3d- and 4d-AgNPs are highly  stable under a wide concentration range of KCl in 
comparison to the condition in a biological system. Such results represent exciting opportunities 
of using these peptide-AgNPs in some biological applications like in antibacterial studies (see 
Chapter V) where the media could have high ionic strength.
4.6.8 Generation of AgNPs in Solution in the Presence of Other Peptides Identified Within 
the Combinatorial Screening of Library 1
As evidence to show that  other peptides identified from the combinatorial screening are also able 
to control the formation of AgNPs of different  sizes, results from solution phase studies are given 
below for the Ac-His-ProAib-Ser-NH2 5 and Ac-Asp-Ahx-Ser-NH2 6 peptides (Figure 80). The 
linkers used to connect the active amino acids were chosen at random among the linkers which 
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were hits from the combinatorial screening results. For Ac-His-ProAib-Ser-NH2 5 the linker 
chosen was Pro-Aib whereas Ahx was chosen to connect Asp with Ser in 6 (Figure 80)
          
  5        6
Figure 80: Structures of peptides Ac-His-ProAib-Ser-NH2 5 and Ac-Asp-Ahx-Ser-NH2 6 which 
were used in AgNP formation
From the combinatorial screening, peptides bearing His and Ser residues gave red or dark orange 
colored beads whereas combinations between Asp and Ser gave yellow colored beads. Hence one 
would expect bigger sizes of AgNPs to be generated by peptide Ac-His-ProAib-Ser-NH2 5 and 
smaller sizes to be formed in the presence of peptide Ac-Asp-Ahx-Ser-NH2 6. The optimised 
conditions were used for the generation of AgNPs in the presence of peptides 5 and 6, that  is at 
pH 12 and peptide/Ag+ ratio of 5.
Figure 81 show the UV spectra as well as the TEM  results of the AgNPs which were generated in 
the presence of peptides 5 and 6. Different morphologies of AgNPs such as triangles or hexagons 
were generated in the presence of the Ac-His-ProAib-Ser-NH2 5 (Figure 81). These morphologies 
are similar to those formed in the presence of the sequence Ac-His-Ahx-Asp-NH2 3d, also the 
average size of 40 nm AgNPs was comparable under similar conditions (Figure 56). This should 
not be surprising since the binding affinities of these peptides to Ag+-ions are similar 
(experimental section), hence they are expected to control the growth of AgNPs in a similar 
manner which results in comparable sizes of AgNPs.
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  a)        b)
  
             
  
5
≤ 40 nm      
6
≤ 15 nm
Figure 81: UV-Vis spectra and TEM  pictures (scale bar = 40 nm) of 5-AgNPs (a) and 6-AgNPs 
(b) generated at pH 12 (results presented were taken at 3 month)
The sizes of AgNPs (≤ 15 nm) which were formed in the presence Ac-Asp-Ahx-Ser-NH2 6 are 
also similar to the sizes of AgNPs which were generated using the Ac-Ser-Ahx-Tyr-NH2 4d 
peptide. Surprisingly, the binding affinity of Ac-Ser-Ahx-Tyr-NH2 4d (-4.2 ± 0.34 kcalmol-1) 
differ from that of Ac-Asp-Ahx-Ser-NH2 6 (-7.0 ± 0.87 kcalmol-1).
4.7 Attachment of AgNPs on Glass Support
Infections on implant devices are an increasing concern.34 Since silver nanoparticles are 
antibacterial,11e attachment of these nanoparticles on the surface of implant devices could serve as 
a versatile tool in addressing this problem. Peptides are known to be biocompatible11 therefore 
they  could be good additives for the generation of AgNPs for antibacterial applications. 
Furthermore, peptides could improve nanoparticle dispensability and chemical stability during 
the application of these nanoparticles in different fields. 
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We explored the efficiency of incorporating our AgNPs on surfaces to use them in antibacterial 
studies. Mirkin et  al. reported a procedure of attaching AgNPs on activated glass surface,35 hence 
we used glass microscope slides as a reaction model (Figure 82). Our investigation involved 
activating the glass slides followed by attachment of our already prepared AgNPs which were 
generated in the presence of peptide 3d at pH 10 and pH 12 (Figure 55 and 56). For peptide 4d 
the AgNPs which were used in this evaluation were generated at pH 12 (Figure 58).
Figure 82: General scheme for functionalising glass surface and attachment of AgNPs 35
We pretreated the glass slide with a solution of H2SO4 and HNO3 for cleaning and activation of 
the glass surface and then, under acidic conditions introduced reactive primary amine 
functionalities using 3-aminopropyltrimethoxysilane (Figure 82).35 The modified glass substrates 
were rinsed thoroughly with nanopure water before use.
The silanised glass slides where then immersed for 24 hours in a solution of previously 
synthesized AgNPs. Following washing with nanopure water, the characterization of the 
nanoparticles was carried out by SEM analysis (Figure 83).
In all cases, the SEM images show a monolayer of AgNPs which are attached to the glass 
surface. Overall, the sizes of the AgNPs are within similar ranges to the size before attachment 
onto the glass surface. Like other studies,35 there is no significant tendency observed for the 
nanoparticles to stack in a face-to-face manner. Such tendency could be overcome by the 
electrostatic interactions between the amine-coated glass slide and probably  the peptide which is 
protecting the AgNPs.
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3d-AgNPs (pH 12)
 ≤ 50 nm     
3d-AgNPs (pH 10)
 ≤ 20 nm
      c)     
   
      
4d-AgNPs (pH 12)
 ≤ 15 nm
Figure 83: SEM images of AgNPs on activated glass slide surface generated in the presence of 
peptide 3d at pH 12 (a) and pH 10 (b) whereas (c) shows SEM image of 4d-AgNPs generated at 
pH 12
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V.
ANTIBACTERIAL STUDIES
Silver nanoparticles have been known for a long time to be antibacterial.21,36 Since then there has 
been a wide range of healthcare products where AgNPs are incorporated and examples include 
medical devices, burn dressings and water purification systems.37
For antibacterial activity, the dimensions of AgNPs play a major role and studies showed smaller 
nanoparticles to have greater antimicrobial effect  than larger ones.21,36 Hence, different methods 
have been reported to prepare AgNPs for potential applications as antibacterials. Apart from the 
size, the shape of AgNPs has also been reported to play a significant role in their antimicrobial 
effect.38 Pal et al. found that triangular AgNPs had greater antibacterial action than either rod or 
spherical nanoparticles.39 The enhanced antibacterial effect of triangular AgNPs was assumed to 
be due to a higher fraction of active faces present in these shapes. This proposition was supported 
by X-ray diffraction studies where the diffraction patterns of triangular nanoparticles were found 
to have more high-atom-density facets than other shapes, favouring the reactivity of silver. 
In the generation of AgNPs, the control of the shape and size for enhanced antibacterial 
applications still poses a great challenge. We envisioned the use of our highly stable peptide-
AgNPs as antibacterials to be effective approach to address this challenge. Two different sizes of 
AgNPs derived from peptides were used, 3d-AgNPs (20 nm) and 4d-AgNPs (≤15 nm). 
Staphylococcus epidermidis was used as bacteria model to investigate the antimicrobial activity 
of silver nanoparticles. This strain of Staphylococcus produces large quantities of biofilm and 
post operative infections of the implants which complicate treatments.40
Isothermal Micro Calorimetric (IMC) technique was used to probe bacterial growth at varying 
amounts of AgNPs. The versatility of IMC is its ability to detect changes in heat production rate 
as low as 22 nJ/s equivalent to a change of only  ~104 in the number of active bacteria present.41 It 
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is thus a non-invasive method for detecting and quantifying growth kinetics of bacteria in a liquid 
culture.
To compare the antibacterial activity of AgNPs generated by non-peptide ligands, citrate 
stabilized AgNPs (≤15 nm in diameter) were also prepared (Figure 84).42
   a)      b)
 
     c)
   
Figure 84: TEM pictures (scale bar = 40 nm) of 3d-AgNPs (a), 4d-AgNPs (b) and citrate-AgNPs 
(c) applied in antibacterial studies
The citrate-AgNPs have a considerably lower stability (≤ 24 h) than AgNPs induced in the 
presence of peptides 3d and 4d which are stable for several months. Problems associated with 
polydispersity as well as stability of citrate-AgNPs are well known.42
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All medium solutions, micro-calorimetric vials, and caps were sterilized by autoclaving at 121°C. 
Approximately  105 bacteria population and Brain Heart Infusion (BHI) medium were mixed in 3 
mL ampoules together with AgNPs of different concentrations (2, 5, 10, and 20 µg/mL). Controls 
including peptides, vitamin C, citrate and NaBH4 were also prepared and treated under identical 
conditions. The ampoules were sealed with caps prior to loading them into the Isothermal Micro 
Calorimeter. 
The growth inhibition of AgNPs at 37°C was followed as power-time curve recordings on the 
computer (Figure 85). The generated power-time curves were integrated using the R-programme 
to obtain the heat  over time curve.43a-b As these curves are considered as proxy  for the growth 
curves,44 they  were fitted using the Richards equations by applying the grofit package for R.43a.b 
This allowed calculating the maximum growth rate (µ) and the lag phase duration (λ) both of 
which are affected by the AgNP.
Interestingly  Figure 85a shows a change in the pattern of the heat flow curves. In this case with 
increase in the concentration of 3d-AgNPs results in a decrease of the maximum heat flow 
indicating a lower metabolic activity. The nature of these curves indicates the unique behavior of 
3d-AgNPs which are both bactericidal (kill bacteria) and bacteriostatic (slow the growth of the 
surviving bacteria).
Furthermore, 3d-AgNPs reveal a concentration dependent antibacterial effect. This is supported 
by the increase in the lag phase (λ) as well as the relative gradual decrease of the growth rate 
constant (µ) of the Staphylococcus epidermidis with an increase in the concentration of 
nanoparticles (Figure 86a). 3d-AgNPs are relatively  larger than the pores on the cell membrane 
of bacteria.45 Larger size of AgNPs have smaller surface area to interact with bacterial cell 
functions to cause physiological damage. Permeability of these bulkier nanoparticles into the 
bacteria’s cell is limited.
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Figure 85: Effect of AgNPs on bacterial growth in the presence of 3d-AgNPs (a), 4d-AgNPs (b) 
and citrate-AgNPs (c)
On the contrary, the smaller sizes (≤15 nm) 4d-AgNPs are only  bactericidal since there is no 
significant decrease in the gradient of the heat flow curves with an increase in the concentration 
of the nanoparticles (Figure 85b). In addition, Figure 86b shows that 4d-AgNPs kill bacteria 
more efficiently than 3d-AgNPs which is supported by  considerably higher increase in the lag 
phase (λ) of bacterial growth when the concentration of the nanoparticles was increased.
104
   a)       b)  
 
   
Figure 86: Effect of AgNPs on bacterial growth in the presence of 3d-AgNPs (a), 4d-AgNPs (b)
   
Figure 87: Effect of AgNPs on bacterial growth in the presence of citrate-AgNPs
Surprisingly, 4d-AgNPs show a decrease followed by  a gradual increase in the maximum growth 
rate (µ) of the Staphylococcus epidermidis with respect to an increase in the concentration of 
nanoparticles (Figure 86b). More bacteria than in the presence of 3d-AgNPs are killed soon after 
inoculation with 4d-AgNPs. However, the selection pressure applied by AgNPs might result in 
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favouring growth AgNP resistant mutants. These mutants would in turn have a slightly higher 
growth rate in the presence of AgNP, thus explaining the unexpected increase in the maximum 
growth rate (µ) with an increase in concentration of 4d-AgNPs (Figure 86b). In this context it 
must be noted that this increase does not compensate the initial drop of the maximum growth rate 
(µ). Because 4d-AgNPs are in the size range of bacteria’s cell membrane pores, their 
permeability  into bacteria cell is easier and faster than 3d-AgNPs.45 Furthermore, the difference 
in the antibacterial action between 3d- and 4d-AgNPs could be due to the difference in the shape 
of AgNPs since shape could also be a decisive factor in the antibacterial effect.38 Unfortunately 
the exact shapes of our generated AgNPs have not been determined since efforts to access a high 
resolution TEM machine coupled with a diffractometer have not been successful.
Citrate-AgNPs have the highest antibacterial activity compared to both 3d- and 4d-AgNPs.
(Figure 85 and 87). Since smaller AgNPs are known to be more antibacterial than bigger AgNPs, 
the antibacterial activity trend 3d < 4d < citrate-AgNPs is as expected (Figure 85). Due to their 
size, citrate-AgNPs can pass easily into bacterial cell to cause the most physiological damage. 
Furthermore citrate-AgNPs have the largest surface area available for interaction with bacteria 
cell functionalities thereby expressing more antibacterial activity than either 3d- or 4d-AgNPs.46
Even though citrate-AgNPs displayed the highest antibacterial activity, the stability  (< 24 h) of 
these AgNPs limit their applicability as compared to 3d- or 4d-AgNPs (at  least 3 months). 
Overall, these results show that for the enhancement of antibacterial activity future peptide-
AgNPs should be designed in the size range of the citrate-AgNPs or lower.
Intriguingly, the Isothermal Micro Calorimetry approach can easily follow and clearly  display 
antibacterial activity of smaller (≥15 nm) AgNPs at very low concentration (2 µg/mL) of AgNPs.
In our experimental conditions, the controls including peptides, vitamin C, citrate and NaBH4 
showed no antibacterial activity  against Staphylococcus epidermidis. These results indicate that 
AgNPs were the contributing agents for the observed antibacterial activity.
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VI.
SUMMARY AND OUTLOOK
6.0 Summary 
Different peptides induce AgNPs in different sizes on solid support and these nanoparticles have 
very high stabilities (several months). This study has shown that there is no significant effect of 
the linker and the stereochemistry of the amino acid in the formation of AgNPs. 
Notably, this report has shown that short peptides bearing imidazole, carboxyl and hydroxyl 
functional groups can generate AgNPs with high stabilities of at least 3 months in solution 
without use of an additional stabilizer. The reduction of Ag+ and the formation of AgNPs of a 
given size depend not only on the ratio of peptide/Ag+ but also to a large extent on the 
combination of different amino acids in the peptide sequence. In this regard, AgNPs that were 
generated in the presence of the His/Asp peptide were found to be larger on average than those 
produced under identical conditions using the Ser/Tyr peptide. These results also demonstrate that 
the synergistic effect  of amino acids in peptide sequences and the reaction conditions (for 
example pH of the reaction medium) can easily modulate the affinity  of short peptides for Ag+ 
ions and AgNPs resulting in different size and shape. Alteration of these parameters has shown to 
result in the production of AgNPs of diverse shapes (spherical, quasi-spherical, triangular and 
hexagonal nanoplates) and sizes ranging from around 5 to 60 nm and stabilities of up to 3 
months. 
Additionally, this study is anticipated to promote easy understanding of the roles which amino 
acids in short peptides play in the formation of AgNPs of different sizes. Expansion of this 
powerful knowledge could allow for the large assembly  of AgNPs in different size and shape by 
using different peptides and reaction conditions. 
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Most importantly, these findings demonstrate an easy approach of generating AgNPs of different 
sizes for antimicrobial studies. Isothermal Micro Calorimetry is a versatile sensitive technique to 
investigate the activity of bacteria at different concentrations of AgNPs. This report  provides a 
basis for the measurement of size-dependent antibacterial activity of AgNPs. Bigger 
nanoparticles (≤ 20 nm), 3d-AgNPs have the ability to slow the growth rate and also kill bacteria 
at the same time. As expected, the antibacterial activity  of AgNPs was found to be size and 
concentration-dependent and in the observed trend 3d < 4d-AgNPs. Therefore the size and 
concentration of AgNPs are very important considerations in the application of AgNPs as 
antibacterial agents. However, the mechanism through which AgNPs manifest antibacterial 
properties still remain to be explored.
6.1 Outlook 
Further AgNP characterization using other techniques like TEM coupled with an electron 
diffractometer can help to understand the crystalline nature of the AgNPs. In addition the use of a 
high resolution TEM could identity the actual shapes of AgNPs. In particular, the AgNPs that are 
of sizes of less than 30 nm could not be clearly imaged by the readily available normal TEM to 
reveal the shapes.
So far the purification of AgNPs has not been successful. Future studies can be done using 
dialysis tubes. Thermogravimetric analysis (TGA) on the purified AgNPs could give information 
on the presence of peptides anchoring on the surface of nanoparticles. This information helps in 
understanding the role of peptides in the formation of AgNPs. 
Furthermore TGA analysis can also reveal the number of peptides which are available per 
nanoparticle. For biological applications like the targeting of organs, it is achieved by  conjugating 
to nanoparticles, a biomolecule that selectively  binds a receptor over-expressed on the target.47-48 
The knowledge of the number of peptides per given nanoparticle helps in the design of the 
nanoparticle-biomolecule model.
Expanding this research into medical devices that  are frequently colonized by Staphylococcus 
epidermidis and the coating of the surface of such devices with peptide-AgNPs could address 
this big challenge. Since attachment of  AgNPs on activated glass slides has been successful, 
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future studies can be extended to antibacterial studies of AgNPs which are attached to the surface 
of glass. To overcome problems that could be associated with inefficient access of AgNPs on the 
flat glass slides to antibacterial activity, the use of spherical glass beads can be considered.
To understand how our AgNPs kill bacteria, bacteria cells from bioassays can be sliced and then 
imaged by high resolution TEM to check if AgNPs also enter the bacterial cell. Evidence of 
AgNPs inside the cells could furthermore support the hypothesis that the AgNPs cause 
physiological damage by interacting with cell functionalities like DNA.
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VII.
SPLIT-AND-MIX LIBRARY 2
The proceeding two chapters highlight the preliminary studies that have already been carried out 
in the generation of AgNPs as well as platinum nanoparticles (PtNPs) by new peptides identified 
after the combinatorial screening of the new encoded peptide library 2.
The success in using library 1 to identify  peptides that are able to induce the formation of AgNPs 
motivated us to enlarge the diversity of peptides by synthesising a bigger library 2 (Figure 88). It 
consists of nine times more peptide library members (3 375) than library 1 (375). Moreover, it is 
constructed from additional amino acids which are not part of library 1. It consists of 15 different 
L- and D- amino acids in positions AA1 and AA2 as well as 15 different linkers (Figure 88).
Figure 88: The newly synthesised encoded peptide library 2
Most of the amino acids in position AA1 and AA2 have functional groups like N- or O- donors as 
well as aromatic groups that can coordinate to silver. Linkers comprise of amino acids which are 
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either flexible or turn inducing rigid motives to allow for large structural peptide diversities 
(Figure 88). 
Moreover, the new library 2 is designed with possibility for the peptide library members to have 
their N-termini either free or acetylated. This allows for easy screening in the identification of N-
termini free or acetylated peptides which are able to induce the formation of AgNPs. 
7.1 Combinatorial Screening of Ac-Library 2 Without a Reducing Agent
Library 2 was screened under the same screening conditions as for library  1. Interestingly, after 
10 min of treating the acetylated form (Ac-library 2) with an aqueous solution of AgNO3 some 
beads turned orange-to-yellow colour before the addition of sodium ascorbate, or any other Ag+-
ion reducing agent (Figure 89). This was surprising since such a result was not  observed during 
the screening of library 1. 
Figure 89: Light micrograph of Ac-library  2 after incubation with AgNO3 without a reducing 
agent
Isolation of several of the coloured beads from the assay and analysis of the peptides on them, 
revealed the main consensus sequences listed in Table 7. Surprisingly, the peptide consensus 
sequences had a Lys moiety connected to any amino acid without any selectivity  for either Tyr or 
Trp which are known to reduce Ag+ to Ag.9,49 We would have expected most of the sequences to 
comprise of Tyr or Trp  connected to a basic amino acid like Lys or Arg. Like the findings to 
library 1, the linker and the stereochemistry of the amino acids were found to be random.
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AA2   Linker  AA1
D-Lys   D-Leu   Trp
D-Lys   Val   Ala
D-Lys   Pro-Gly   Glu
D-Lys   Pro   Trp
D-Lys   -   Ala
D-Lys   -   D-His  
Val   Val   Lys
Asp   Ala   Lys
His   Ala   Lys
D-Ala   D-Leu   Lys
Tyr   D-Val   Lys
D-Ala   Pro-Gly   D-Tyr
Table 7: Peptide sequences found on coloured beads after treating Ac-library 2 with AgNO3 
without a reducing agent
Similar findings of Lys being able to reduce Ag+ to Ag0 were reported by Aroca et al.9,10 
Encouraged by  these results, we resynthesized some of the active peptides to check if they are 
also able to induce the formation of AgNPs as individual sequences without sodium ascorbate as 
additive. 
7.2 Ag-Nanoparticle Formation by Peptides Immobilized on Solid Support 
Among the sequences we investigated, as examples we chose peptide Ac-Lys-Pro-Trp-resin 7a 
which contain a Ag+ reducing agent Trp  (Table 8). Moreover we chose peptide Ac-Asp-Ala-Lys-
resin 8a which contain an acid to check if the formation of AgNPs can take place in the presence 
of an acidic group without sodium ascorbate as an additive.
 Ac-D-Lys-Pro-Trp-resin 7a
 Ac-Asp-Ala-Lys-resin 8a
Table 8: Peptide 7a and 8a used in AgNP formation
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In the formation of AgNPs, we treated peptides 7a and 8a under the same conditions as to the 
library screening. As in the combinatorial assay, after 10 minutes of incubating the peptides with 
an aqueous solution AgNO3, the beads became orange coloured (Figure 90 and 91) thereby 
confirming the combinatorial screening results. SEM  analysis also confirmed the presence of 
AgNPs on the surface of beads (Figure 90 and 91). On average peptide 7a induces AgNPs of 
sizes of approximately  20 nm that can form assemblies of 200 nm (Figure 90). Similar 
morphologies of the AgNPs are observed for peptide 8a (Figure 91). The source of electrons in 
the Lys reduction of Ag+ is yet to be fully investigated. 
     
  
   
Figure 90: Light micrograph and SEM pictures of Ac-D-Lys-Pro-Trp-resin 7a-AgNPs
113
   
     
Figure 91: Light micrograph and SEM pictures of Ac-Asp-Ala-Lys-resin 8a-AgNPs
7.3 Combinatorial  Screening of Ac-Library 2 in the Presence of a Reducing Agent (Sodium 
Ascorbate)
To gain more insight into the ability of Ac-library 2 to identify peptides that are able to induce the 
formation of AgNPs we treated the library with AgNO3 followed by sodium ascorbate. 
Visualization of the assay  under the Light microscope showed beads with a diversity of colours 
(Figure 92). 
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Figure 92: Light micrograph of Ac-library 2 after incubation with AgNO3 followed by sodium 
ascorbate
Isolation of several of the coloured beads from the assay and analysis of the peptides on them, 
revealed the main consensus sequences listed in Table 9. It  was encouraging to find that  some of 
the peptide sequences in Table 9 are similar to the sequences we have already  found after 
screening library  1 (Table 3). Like library  1, the results show that the linker and the 
stereochemistry of the amino acid are random, hence play an insignificant role in the formation of 
AgNPs. 
AA2   Linker  AA1  Bead colour
Ser   Pro-Gly  D-His  red
D-Ala   D-Leu   D-His  red
D-Lys   Ala   D-Asp  red
D-Trp    Pro-Aib  D-Asp  red
Thr   D-Leu   Asp  red
D-Glu   D-Phe   Glu  red
Ala   Phe   D-Glu  red
Val   Pro-Aib  Thr  red
Ser   _   D-Ser  red
His   Phe   D-Tyr  orange
His   Pro   Thr  orange
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His   _   Ala  orange
Asp   D-Leu   D-Arg  orange
Tyr   Leu   D-Arg  orange
D-Glu   Pro-Gly  D-Tyr  orange
D-Lys   Pro   Trp  orange
Ser   Gly   Lys  orange
D-Pro   Pro   Pro  orange
   
D -Trp    D-Phe   D-Ser  yellow
D-Trp    Pro-Gly  Ala  yellow
D-Trp    Pro-Aib  Thr  yellow
D-Trp    Pro-Aib  Trp  yellow
D -Pro   Gly   Trp  yellow
D-Phe   (1S,2S)-Achc  Trp  yellow
D-Pro   Leu   Phe  yellow
D-Ala   Pro-Gly  D-Asn  yellow
Ser   D-Phe   D-Asn  yellow
Table 9: Peptide sequences found on coloured beads after treating Ac-library 2 with AgNO3 and 
sodium ascorbate.
7.4 Ag-Nanoparticle Formation by Peptides Immobilized on Solid Support
Based on the combinatorial screening results, we then investigated the ability of the peptides to 
generate AgNPs as individual sequences as well as to validate the combinatorial screening 
results. We chose peptide sequences which were expected to allow for easy comparison to the 
results that were achieved in the investigations with sequences identified after screening library 1. 
As examples, 9a containing Ser with His residue found on red colored beads, 7a containing Lys 
with Trp residue found on orange colored beads and 10a containing Trp with Ser found on yellow 
coloured beads (Table 9). The linkers and the stereochemistry of the amino acid were chosen as 
they appear as hits from the combinatorial screening studies.
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Ac-Ser-Pro-Gly-D-His-resin  9a
Ac-D-Lys-Pro-Trp-resin  7a
Ac-D-Trp-D-Phe-D-Ser- resin  10a
Table 9: Peptides chosen from the combinatorial screening results to investigate the formation of 
AgNPs on solid support 
Peptides bound on Tentagel resin were treated under the same conditions as previously discussed 
during the generation of AgNPs. Visual inspection of the treated beads under a light microscope 
revealed that the beads bearing the Ac-Ser-ProGly-D-His 9a had turned red, those with the Ac-
Lys-Pro-Trp 7a were dark orange and the Ac-D-Trp-D-Phe-D-Ser 10a were yellow thereby 
confirming the combinatorial screening results (Figure 93 and 94).
SEM analyses of the bead-bound AgNPs showed that the dark orange color from the Ac-Ser-
ProGly-D-His 9a corresponds to silver nanoparticles with an average diameter of approximately 
70 nm (Figure 93b). AgNPs induced by the Ac-Lys-Pro-Trp sequence are of approximately 20 nm 
in diameter whereas the yellow colour on the Ac-D-Trp-D-Phe-D-Ser beads are due to smaller 
sizes of AgNPs of about 15 nm in average size (Figure 94). These results further confirm that 
different peptides induce selective formation of AgNPs in different sizes on bead.
    a)      b)
   
Figure 93: Light microscopic (a) and SEM (b) pictures for AgNPs generated in the presence of 
peptide Ac-Ser-ProGly-D-His 9a
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   a)       b)
 
   c)       d)
  
Figure 94: Light microscopic (a and c) and SEM (b and d) pictures for AgNPs generated by 
peptide sequences 7a (left) and 10a (right)
7.5 Ag-Nanoparticle Formation by Peptides in Solution Phase
We also investigated if peptides 9b, 7b and 10b are able to generate AgNPs in solution as they 
did on solid support. Preliminary  studies in the generation of AgNPs have been done at the 
optimized conditions as discussed for peptide sequences identified in library  1, that is at pH 12 
and peptide/Ag+ ratio of 5.
The UV-visible spectra show the development of a weak surface plasmon resonance (SPR) band 
at around 422 nm which is noticeable after a week for the AgNP formation in the presence of the 
Ac-Ser-Pro-Gly-D-His-NH2 9b (Figure 95a). TEM  analysis reveal AgNPs of about 40 nm in 
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average diameter which corresponds to the observed weak SPR. The size of the AgNPs is 
comparable to the size obtained when a similar peptide Ac-His-Pro-Aib-Ser-NH2 5 was used in 
the generation of AgNPs under the same conditions (Figure 81). 
The generation of AgNPs in the presence of the Ac-D-Lys-Pro-Trp-NH2 7b is faster in 
comparison to the use of Ac-Ser-Pro-Gly-D-His-NH2 9b peptide (Figure 95a). Since previous 
studies have shown that the His amino acid is a strong binder of Ag+, this could explain the 
observed differences in the AgNP formation between the stronger Ag+ binding peptide Ac-Ser-
Pro-Gly-D-His-NH2 and the Ac-D-Lys-Pro-Trp-NH2 peptide could be a weaker binder (Figure 
95b). ITC studies in the presence of these peptides is expected to give more information about the 
binding strength of the peptides to Ag+-ions as well as to AgNPs. TEM results show that Ac-D-
Lys-Pro-Trp-NH2 7b induce the formation of smaller size of nanoparticles of 20 nm in average 
diameter. These nanoparticles corresponds to the SPR band centered at 418 nm (Figure 95b).
As expected Ac-D-Trp-D-Phe-D-Ser-NH2 10 induces the formation of smaller sizes of AgNPs of 
approximately 15 nm in size. The UV-spectra show an absorption band around 418 which is due 
to the presence of these small sizes of AgNPs (Figure 95c).
These studies have shown that peptides identified from the combinatorial screening of Ac-library 
2 are also able to generate different sizes of AgNPs in solution. AgNPs which are generated in the 
presence of Ac-D-Lys-Pro-Trp-NH2 and Ac-D-Trp-D-Phe-D-Ser-NH2 in solution or on solid 
support are of the same size, 20 nm and 15 nm respectively.
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     a)
     b)
     c)
Figure 95: UV-Vis spectra and TEM pictures (scale bar = 40 nm) for AgNPs generated by peptide 
sequences 9b (a), 7b (b) and 10b (c) (results presented were taken at 1 week).
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7.6 Combinatorial Screening of NH2-Library 2 Without a Reducing Agent
Studies that were carried out on the active peptides identified after the combinatorial screening of 
library 1 could not clearly demonstrate if the N-termini on peptides could influence the 
generation of AgNPs. For that reason, the easy flexibility of library  2 to have its peptides N-
termini free was taken advantage to screen for peptides which can induce the formation of 
AgNPs. 
After treating library 2 (N-termini free) with AgNO3 followed by incubation for ten minutes 
without adding a reducing agent, some beads turned  orange/yellow in colour (Figure 96). 
Figure 96: Light micrograph of NH2-library 2 after incubation with AgNO3 followed, no addition 
of sodium ascorbate.
Like the results from the screening of the Ac-library 2, most of the peptides identified had a Lys 
connected to any amino acid as previously found after the screening of Ac-library 2 (Table 10). 
On the few peptide sequences identified where the His moiety is connected to Trp, this could 
result in the increase of pH which then raises the reducing power of Trp for Ag+-ions to form 
AgNPs. 
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AA2   Linker  AA1
D-Trp    -   D-His
D-Trp    Ahx   D-His
D-Trp    (1S,2S)-Achc  Lys
Tyr   Ahx   Lys
Glu   D-Le    Lys
D-Phe   -   Lys
D-Lys   Pro   Phe
D-Lys   -   D-Asp
D-Lys   Ahx   Arg
Arg   (1R,2R)-Achc  D-His
Table 10: Peptide sequences found on coloured beads after treating NH2-library 2 with AgNO3, 
no addition of sodium ascorbate.
Further investigations in the generation of AgNPs in the presence of peptides bound on solid 
support could give more insight  into the source of electrons during the reduction process. This 
could involve protecting the -NH2 side group and investigate if the reduction of Ag+ still takes 
place without an external reducing agent.
7.7 Combinatorial Screening of NH2-Library 2 in the Presence of Sodium Ascorbate
NH2-library 2 was also treated with AgNO3 and then sodium ascorbate in order to investigate if 
different peptides will be obtained compared to the results obtained after the screening of the Ac-
library 2. Another aim of screening NH2-library 2 was to identify peptides which are able to 
induce the formation of AgNPs when their N-termini are free.
Differently coloured beads were obtained upon treatment of NH2-library 2 with AgNO3 and 
sodium ascorbate (Figure 97). 
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Figure 97: Light micrograph of NH2-library 2 after incubation with AgNO3 followed by sodium 
ascorbate
Several coloured beads from each colour category of the assay were isolated. Following DMF 
washing of the beads, they were irradiated under high intensity UV light, liberating the tag 
alcohols contained on each bead. Subsequent EC-GC analyses of the sequences on the beads 
revealed that most of the red coloured beads consists of His connected to Glu or Asp (Table 11). 
This confirms that this combination of amino acids is crucial for the generation of AgNPs of a 
large size. The Phe and Tyr moieties are the most predominant amino acids in the category of the 
yellow coloured beads. In all cases the linker and the stereochemistry  of the amino acid do not 
play a significant role.
AA2   Linker  AA1   Bead Colour
His   D-Phe   Glu  red X 2
His   Phe   Glu  red
His   D-Val   Glu  red X 2
His   D-Leu   Glu  red
His   Phe   D-Asp  red
His   Val   D-Asp  red
His   Ala   D-Asp  red
His   (1S,2S)-Achc  D-Asp  red
D-Phe   Val   D-His  red
D-Lys   D-Leu   Lys  red
D-Trp    Val   Glu  red
Asp    Pro-Gly  D-Asp  red
123
AA2   Linker  AA1   Bead Colour	
  
	
   	
   	
  
D-­‐Thr	
   	
   	
   (1R,2R)-­‐Achc	
   	
   D-­‐Asp	
   	
   orange
Val    Ala   D-Asp  orange
D -Gln   D-Phe   D-Asp  orange X 2
D-Thr   Phe   Glu  orange
D-Ala   _   Glu  orange
D-Pro   Val   D-His   orange
D-Ala   Ahx   His   orange
His   D-Val   D-Arg  orange
D-Trp    Ahx   D-Arg  orange
Arg   (1R,2R)-Achc  Pro  orange
Arg   D-Val   Pro  orange
Val    _   Trp  orange
D-Phe   Ahx   Lys  orange
   
L Tyr   Pro-Gly  D Tyr  yellow
L Tyr   Phe   D Tyr  yellow
D Pro   Phe   D Tyr  yellow
D Phe   Pro   Thr  yellow
D Ala   Val   Phe  yellow
D Glu   (1R,2R)-Achc  Phe  yellow
D Thr   D-Phe   Phe  yellow
L Val   D-Val   Phe  yellow
D Ala   D-Phe   D-Ser  yellow
L Val   Phe   Glu  yellow
L Val   D-Leu   Thr  yellow
D Lys   D-Val   Glu  yellow
Table 11: Peptide sequences found on coloured beads after treating NH2-library  2 with AgNO3 
and sodium ascorbate
Future studies involve re-synthesis of the active peptides as well as AgNP formation on solid 
support and in solution get more information on the generation of AgNPs.
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IX.
PLATINUM NANOPARTICLES
9.0 Platinum Nanoparticles (PtNPs)
Over the past decade, platinum nanoparticles have been extensively explored due to their unique 
properties for new applications and improving current applications.1 Recently  the potential 
application of PtNPs in cancer radiation treatment has been reported.2 Studies have shown that 
the size and shape of PtNPs play crucial roles in their applications.3-7 Due to their synthetic 
challenge, to date the generation of PtNPs is often done at high temperature.8-9 Quite often the 
resulting nanoparticle products have drawbacks in different applications due to insolubility in 
water. Although there have been some reports on the synthesis of water-soluble PtNPs some of 
which include the use of peptides, the control of size and size distributions still poses a great 
challenge.1,8-10
Since we had synthesised library  2 which is decorated with fucntioanal groups that could 
coordinate to Pt+2. We decided to test this library for peptides that are able to generate PtNPs. For 
the first experiments, we started by screening the Ac-library 2.
9.1 Combinatorial Screening of Encoded Split-and-Mix Library 2
Following the incubation of approximately 10 mg resin of Ac-library 2 with an aqueous solution 
of K2PtCl4, the resin was treated with an aqueous solution of NaBH4. The screening was 
evaluated using a light microscope. 
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Figure 97: Light micrograph of Ac-library 2 after incubation with K2PtCl4 followed by NaBH4
Figure 97 show the light  microscopic image of differently  coloured beads after the treatment with 
K2PtCl4 followed by  NaBH4. Following isolation and EC.GC analysis of the sequences on the 
beads revealed that the brown coloured beads had predominantly the Ala connected to an Ala 
motive. For the red coloured beads there is high selectivity  for peptides which contain at least an 
Arg moiety. This could be due to the high basicity  of Arg which increases the binding of Pt+2 to 
the peptide resulting in the reduction of Pt+2 to generate PtNPs. Some of the peptides contain a 
His or Lys that shows that the red coloured beads consist of PtNPs that are generated by peptides 
whose ligand groups are basic.
Under the yellow coloured bead category, it  is difficult to generalize the amino acid combinations 
which induce the formation of PtNPs. Picking more yellow coloured beads from library 2 
combinatorial assay and analyse them could help to confirm these results. 
In all of the colours generated, the rigid linker has higher occurrence on peptides identified by 
GC analysis (Table 12). Since the attachment of Pt2+ and its reduction, is expected to take place 
near each other, hence the most pronounced occurrence of the rigid linker show that the spatial 
arrangement of the active peptides is important for PtNP formation.
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AA2   Linker  AA1  Bead colour
D-Ala   Ala   Ala  brown X 7
D-Ala   (1S,2S)-Achc  Ala  brown X 4
D-Ala   D-Phe   Ala  brown X 2
D-Phe   D-Phe   Ala  brown
Ser   (1S,2S)-Achc  Ala  brown
Arg   (1S,2S)-Achc  Trp  brown
Arg   _   Trp  brown
   
D-Ala   (1S,2S)-Achc  D-Arg  red X 2
D-Ala   (1R,2R)-Achc  D-Arg  red
D-Ala   D-Phe   D-Arg  red
D-Ala   Ahx   D-Arg  red
Ser   (1R,2R)-Achc  D-Arg  red
Ser   (1S,2S)-Achc  D-Arg  red
D-Glu   Pro   D-Arg   red X 2
D-Trp    Pro   D-Arg  red
D-Thr   Pro-Gly  D-Arg  red 
  
D-Ala   (1S,2S)-Achc  Glu  yellow
D-Ala   Gly   D-Arg  yellow
Ser   _   D-His  yellow
D-Trp    Ahx   D-His  yellow
Arg   Leu   D-His  yellow
His   Ahx   Thr  yellow
D-Lys   (1R,2R)-Achc  D-Asn  yellow
D-Thr   D-Val   Lys  yellow
Val   Pro-Aib  D-Ser  yellow
D-Pro   Ahx   D-Ser  yellow
Table 12: Most often found peptide sequences on coloured beads after EC-GC analysis 
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To confirm the presence of PtNPs on the surface of the coloured beads, resynthesis of the active 
peptides could be done and then generate PtNPs using the procedure similar to the combinatorial 
screening. SEM studies could then be done on the surface of beads to confirm the presence of 
PtNPs. Due to the limited time such studies have not yet been done.
Conclusion
Ac-library 2 could be a suitable tool to identify  peptides which are able to form PtNPs. 
Differently cloured beads were generated after treating the library with K2PtCl4 salt followed by 
NaBH4. Differently coloured beads could denote diferent sizes of PtNPs on bead. Furher studies 
using SEM could give the relationships of sizes among the identifed active petides.
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XI.
EXPERIMENTAL
11.0 General Aspects 
Materials and reagents were of the highest  commercially available grade and used without further 
purification. The reagents and solvents used in this work were obtained from Aldrich, Fischer, 
Fluka, Cambridge Isotope Laboratories and Acros chemical supplies. Amino acids were 
purchased from Bachem and IRIS Biotech. Resins for solid phase synthesis were obtained from 
Novabiochem (Merck Biosciences) or Rapp Polymere AG.
For all the solution and the washing steps only  nanopure/ultrapure water was used. Sodium 
ascorbate, AgNO3 and NaBH4 solutions were prepared fresh. CH2Cl2 (follow abbreviations in 
section XII) was dried by distillation from calcium hydride under nitrogen. Reactions were 
monitored by thin layer chromatography using aluminium-backed Merck silica gel 60 F254 
plates. Compounds were visualized by  UV, KMnO4, ninhydrin or FeCl3 solutions. Yields given 
are based upon chromatographically and spectroscopically (1H and 13C NMR) pure materials.
11.1 Analytical Equipments
1H, 13C and 19F NMR 
The spectra were recorded on a Bruker DPX500 or DPX400 spectrometer. Chemical shifts (δ) are 
reported in ppm using Tetramethylsilane (TMS) or the residual solvent peak as a reference. All 
spectra of 1D and 2D experiments were assigned by COSY, HMQC and HMBC analysis and the 
coupling constants (J) are given in Hertz (Hz). The signals are indicated as s = singlet, d = 
doublet, t = triplet, q = quartet, quin = quintet or m = multiplet.
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Mass spectroscopy 
Electrospray  (ESI) mass spectra were recorded on a Finnigan MAT LCQ spectrometer. Analytical 
grade methanol was used as the carrier solvent, with samples prepared to a final concentration of 
approximately 1 mg/mL. The values are given in atom mass per charge (m/z).
Light microscopy (LM)
Combinatorial assays were analyzed with an Olympus SZX12 light microscope.
Electron capture gas-chromatography (EC-GC) 
EC-GC measurements were performed on a Hewlett  Packard HP 6890 from Agilent. Tag alcohol 
solutions were silylated in situ by addition of BSA (1 µL) and analysed by EC-GC detector 
(temperature gradient: 200-320 ºC in 11 min).
Atomic absorption spectroscopy (AAS)1 
The measurements were performed on Shimadzu AA-6300. Standard solutions of concentration 
1, 2, 4, 6 and 8 ppm were used. HNO3 (10 %) was added to all the solutions to keep  the Ag+-ions 
in solution. Blank solutions were also measured.
Scanning electron microscopy (SEM)
Some of the measurements were carried out  using Philips ESEM  XL 30 FEG or Hitachi S– 4800 
at the Zentrum für Mikroskopie in Pharmazentrum with the University of Basel by  Gianni 
Morson, Marcel Düggelin, Daniel Mathys or Eva Bieler. Other measurements were carried out in 
the Department of Physics in the University of Basel by Jon Agustsson or Dr. Claire Barrett.
X-ray photoemission spectroscopy  (XPS)
XPS measurements were performed by Dr. Laurent Marot in the Department of Physics in the 
University  of Basel. A Leybold EA 10N spectrometer equipped with a twin anode (MgKα 1253.6 
eV and AlKα line) and an X-ray  source providing monochromatic AlKα light for excitation of the 
photoelectrons was used. AgNPs were deposited on a silicon wafer followed by drying at  room 
temperature. The complete surface of the sample was excited and the analyzed area was defined 
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by the settings of the analyzer which was 0.8 cm2. Mathematical analysis of the XPS data was 
made using the software UNIFIT.
UV/Vis spectroscopy
The UV-Vis spectra were recorded in quartz SUPRASIL® (Hellma, Typ 114-QS, d = 10 mm) 
cuvettes or Acryl cuvettes from Semadeni (d = 10mm) with an optical path length of 1 cm on a 
Varian Carry 300 incl. Thermostat. 
Transmission electron microscopy (TEM)
TEM  images were taken on a Philips EM  400 microscope operated at 80 kV. The microscope is 
located at the Zentrum für Mikroskopie in Pharmazentrum in the University of Basel. Samples 
were deposited on carbon-coated copper grids and directly imaged after drying in air. At times 
samples were diluted with ultrapure water before imaging to allow for better imaging conditions.
Isothermal titration calorimetry (ITC)
Isothermal calorimetric (ITC) measurements were carried out to characterize the interaction 
between Ag+-ions with peptides using a Micro Cal VP-ITC instrument operated at 25 ºC. The 
titrations were carried out by stepwise injection of solution from a syringe into the sample cell at 
intervals of 150 s. The syringe was tailor-made such that the tip acts as a blade-type stirrer to 
ensure continuous mixing efficiency at 300 rpm. Using the interactive software, an injection 
schedule was automatically carried out by  setting the number of injections, volume of each 
injection, and time between each injection. The reference cell was filled with ultrapure water 
(1.50 mL) and aqueous peptide solution (1.20 mL) was filled in the titration cell. AgNO3 solution 
(0.30 mL) in ultrapure water was added from the syringe into the titration cell in small steps of 8 
µL. The heat evolved during the interaction of the different species was measured. Control 
experiments were carried out by taking distilled water into the cell and titrated with an aqueous 
solution of AgNO3 from the syringe. In addition an aqueous solution of peptide in the cell was 
titrated with ultrapure water from the syringe.
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Figure 98: ITC titration data describing the interaction of peptide Ac-His-Ahx-His-NH2 2d (a) 
and Ac-His-ProGly-His-NH2 2e  (b) with Ag+ at pH 7.5. The results were obtained after titrating 
(each injection 8 µL) of an aqueous solution of AgNO3 (5 mM) into the calorimetric cell 
containing 1.2 mL of an aqueous solution of peptide (0.5 mM)
    a)     b)     
    
Figure 99: ITC titration data describing the interaction of peptide Ac-His-Ahx-Asp-NH2 3d (a) 
and Ac-His-ProGly-Asp-NH2 3e (b) with Ag+ at pH 7.5. The results were obtained after titrating 
(each injection 8 µL) of an aqueous solution of AgNO3 (2 mM) into the calorimetric cell 
containing 1.2 mL of an aqueous solution of peptide (0.5 mM)
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Figure 100: ITC titration data describing the interaction of peptide Ac-Ser-Ahx-Tyr-NH2 4d (a) 
and Ac-Ser-ProGly-Tyr-NH2 4e (b) with Ag+ at  pH 7.5. The results were obtained after titrating 
(each injection 8 µL) an aqueous solution of AgNO3 (100 mM) into the calorimetric cell 
containing 1.2 mL of an aqueous solution of peptide (2 mM)
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Figure 101: ITC titration data describing the interaction of peptide Ac-His-ProAib-Ser-NH2 5 (a) 
and Ac-Asp-Ahx-Ser-NH2 6 (b) with Ag+ at pH 7.5. The results were obtained after titrating 
(each injection 8 µL) an aqueous solution of AgNO3 (5 mM) into the calorimetric cell containing 
1.2 mL of an aqueous solution of peptide (0.5 mM)
	
   Peptide                         ΔG (kcalmol-1)
2d     Ac-His-Ahx-His-NH2    -8.5 ± 0.06
2e     Ac-His-ProGly-His-NH2   -8.6 ± 0.04
3d     Ac-His-Ahx-Asp-NH2    -5.5 ± 0.12
3e     Ac-His-ProGly-Asp-NH2   -5.8 ± 0.94
4d     Ac-Ser-Ahx-Tyr-NH2    -4.2 ± 0.34
4e     Ac-Ser-ProGly-Tyr-NH2   -4.5 ± 0.69 
5      Ac-His-ProAib-Ser-NH2   -5.6 ± 0.02
6     Ac-Asp-Ahx-Ser-NH2    -7.0 ± 0.87
Table 13: Binding affinities of peptides to Ag+-ions
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11.2 Preparation of Amine-Terminated Glass Slides
Figure 102: General scheme for functionalising glass surface and attachment of AgNPs2
Glass microscope slides were pretreated with Piranha solution (H2O2: H2SO4 1:3, v/v) for half an 
hour and after removal from the cleaning solution they were rinsed with nanopure water. 
Following drying the glass slides in a stream of nitrogen they were immersed in a 2-propanol 
solution of 1% 3-aminopropyltrimethoxysilane in the presence of 0.1 % acetic acid for 5 h. The 
modified glass slides were rinsed with nanopure water to remove silane molecules that were not 
covalently bonded to the glass. Finally the cleaned glass slides were dried in a stream of nitrogen.
2
11.3 AgNPs on the Surface of Tentagel Beads or Glass Slides
Samples were either sputtered with 5 nm Au and measured or measured directly  without pre-
coating with Au.
In order to attach AgNPs on glass slides, dried and modified glass slides are immersed in a 
solution of prepared AgNPs and left for 24 hours. Ultrapure water was used to wash-off AgNPs 
which were not bound electrostatically to the glass slides. This followed drying of the glass slides 
without exposure to light at room temperature. SEM measurements were carried out by Dr. Claire 
Barrett in the Department of Physics at the University of Basel.
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11.4	
  Biological Assays
Antibacterial studies of AgNPs were performed in the Laboratory  of Biomechanics & 
Biocalorimetry  at the University of Basel in collaboration with Prof. Dr. Alma U. Daniels and his 
coworker Dr. Olivier Braissant. The bioassays were investigated using isothermal micro 
calorimetry (IMC).
All medium solutions, microcalorimetric vials, and caps were sterilized by autoclaving at 121°C. 
Approximately  105 of the bacteria population and Brain Heart Infusion (BHI) medium were 
mixed in 3 mL ampoules together with AgNPs of the corresponding concentration (from 0-20 µg/
mL). Controls were also prepared and treated under similar conditions. The ampoules were sealed 
with caps prior to loading them into the Isothermal Micro Calorimeter.
The growth inhibition of AgNPs at  37°C was followed as power-time curve recordings on 
computer. The generated power-time curves were integrated using the R-programme to obtain the 
heat over time curve. As these curves are considered as proxy for the growth curves,3 they were 
fitted using the Richards equations using the grofit package for R.4 This allowed calculating the 
maximum growth rate (µ) and the lag phase duration (λ) both of which are affected by the AgNP.
11.5 General Protocols for Solid-Phase Peptide Synthesis
Peptides were prepared on solid-phase polymeric supports following the general protocols for 
manual or automated Fmoc/tBu peptide synthesis.5 Prior to manual peptide synthesis, reaction 
vessels were silylated to reduce the tendency of the resin beads to stick to the glass surfaces. This 
was achieved through overnight agitation of reaction vessels containing a solution of 10 % (v/v) 
TMSCl in anhydrous toluene. Before use, reaction vessels were washed with CH2Cl2 (5x) and 
dried at 110 oC overnight.
11.5.1 Functionalisation of Rink Amide AM resin 
Rink amide resin was deprotected prior to the first amino acid functionalisation. The deprotection 
process involved addition of 20 % (v/v) piperidine in DMF to the resin (pre-swollen in DMF and 
drained) followed by  agitation for 10 min, draining and rinsing with neat DMF solvent. 
Deprotection was repeated for a further 10 min after which the resin was washed alternatively 
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with DMF and CH2Cl2 (5x each). The coupling of the first amino acid occurred under the same 
conditions as described for general solid phase synthesis using the HCTU/i-Pr2NEt (Protocol A).
Protocol A: Manual peptide synthesis using HCTU/i-Pr2NEt 
i-Pr2NEt (9 eq as a 3 M  solution in NMP) was added to a solution of the Fmoc-amino acid (3.3 
eq) and HCTU (3 eq) in DMF. The coupling mixture was agitated for 2 minutes and then added 
directly  to the amino-functionalised resin (pre-swollen in DMF and drained). The reaction 
mixture was agitated for 45 - 60 min before washing alternatively with DMF (5x) and CH2Cl2 
(5x). A few beads were then sampled and checked for complete coupling using standard tests 
according to the functionalisation of the N-terminus (Chloranil,6 TNBS7 or Kaiser8 test). In the 
case of incomplete functionalisation of the resin, the entire coupling procedure was repeated. In 
the case of complete coupling, the Fmoc deprotection was performed as detailed in the previous 
section.
Protocol B: Manual peptide synthesis using DIC/HOBt 
A solution of the Fmoc-amino acid (2 eq) and HOBt (2 eq) dissolved in the minimum amount of 
DMF necessary was added to the suspension of the amino-functionalised resin (pre-swollen in 
CH2Cl2 and drained). The mixture was agitated for 2 min before addition of DIC (2 eq) and then 
agitated for a further 45-60 min. The suspension was washed alternatively with DMF (5x) and 
CH2Cl2 (5x). The completeness of each coupling was monitored using standard tests according to 
the functionalisation of the N-terminus (Chloranil,6 TNBS7 or Kaiser8 test). In the case of 
incomplete functionalisation of the resin, the entire coupling procedure was repeated. In the case 
of complete coupling, the Fmoc deprotection was performed as detailed in the previous section.
Protocol C: Automated peptide synthesis 
For automated peptide synthesis, a Syro Peptide Synthesizer (MultiSynTech GmbH, Witten, 
Germany) was employed. 
i-Pr2NEt (12 eq as a 3 M  solution in N-methylpyrrolidone) was added to a solution of Fmoc-
amino acid (4 eq) and HCTU (4 eq) in DMF. The activated amino acid was added to the amino-
functionalized resin, swollen in DMF (100 mM  concentration) and the mixture was agitated for 
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1.5 h before washing with DMF (5x). The Fmoc deprotection was performed by  the addition of 
40 % (v/v) piperidine in DMF to the resin (preswollen in DMF). The reaction mixture was 
agitated for 3 min, drained and the piperidine treatment repeated for 10 min. Finally the resin was 
washed with DMF (7x). The entire protocol was then repeated for the next cycle. The final Fmoc 
deprotection was omitted when the corresponding Boc-amino acid was employed for the last 
coupling.
Protocol D: General procedure for N-terminal acetylation
NEt3 (20 eq) followed by Ac2O (20 eq) were added to the amine-functionalised resin (pre-swollen 
in CH2Cl2) to a final concentration of ≈ 100 mM  in CH2Cl2. The mixture was agitated for 1 h and 
then thoroughly  washed alternatively with DMF (5x) and CH2Cl2 (5x). The completeness of 
acetylation was monitored using standard tests according to the preceding functionalisation of the 
N-teminus (Chloranil,6 TNBS7 or Kaiser8 test).
Protocol E: Cleavage from the solid support and isolation of peptides 
The solid supported peptides were cleaved from the Rink Amide resin by agitation in a mixture of 
TFA/CH2Cl2 1:1 v/v for 1 h and then repeated for a further 30 min. The acidic filtrates were 
combined and removal of all volatiles under reduced pressure followed by precipitation with 
Et2O afforded the crude peptides as their trifluoroacetate salts. Peptide salts were then triturated 
with Et2O (at least 3 times) and filtered over a fine glass frit  (grade 3) or a syringe filter, dried 
under high vacuum and used without further purification unless specifically stated.
11.6 General Protocol for Ion Exchange of Peptides
Ion exchange was performed using Dowex® resin (1x2-400) from Sigma-Aldrich or VariPureTM 
IPE tubes from Varian. Nanopure water was used as the eluting solvent and TLC spots were 
visualised with ninhydrin, KMnO4 or FeCl3. Peptide containing fractions were pooled and 
lyophilised thereby obtaining the desalted peptide as a white solid. The absence of TFA was 
confirmed by 19F NMR analysis.
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11.7 Peptides Prepared by Solid-Phase Synthesis
Peptides on solid support were prepared either by  automated or by manual synthesis (Fmoc/tBu 
strategy)5 according to the general procedures and obtained as white solids and in yields of 70 % 
to 85 % unless otherwise stated.
Ac-His-Ahx-His-NHR (R=Tentagel (2a) and R=H (2b))
C20H30N8O4 446.50 g/mol
   
1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 8.81 (d, J = 4.6 Hz, 2H, CHImi), 7.33 (d, J = 6.6 
Hz, 2H, CHImi), 4.73 (dd, J = 8.6 Hz, 5.6 Hz, 1H, CHα His), 4.66 (dd, J = 8.1 Hz, 5.8 Hz, 1H, 
CHα His), 3.23 (dd, J = 13.6 Hz, 5.3 Hz, 2H, CH2β His), 3.16 (t, J = 7.1 Hz, 2H, CH2β His), 
3.07 (m, 2H, NHCH2 Ahx), 2.23 (m, 2H, CH2CO Ahx), 1.96 (s, 3H, CH3 Ac), 1.50 (m, 4H, CH2 
Ahx), 1.21 (m, 2H, CH2 Ahx)
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 176.1, 174.8, 173.4, 172.1, 135.0,134.7, 131.4, 
131.4, 118.4, 118.3, 53.8, 53.1, 40.4, 36.6, 29.9, 28.2, 27.3, 26.3, 22.6, 22.6
ESI-MS: 447.1 [M+H]+ (calcd.: 446.5).
Ac-His-Pro-Gly-His-NHR (R=Tentagel (2c) and R=H (2d))
C21H29N9O5 487.51 g/mol
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1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 8.80 (s, 1H, CHImi), 7.40 (s, 1H, CHImi),  4.89 
(m, 1H, CHα Pro), 4.70 (dd, J = 9.1 Hz, 4.8 Hz, 1H, CHα His), 3.9 (d, J = 17.1 Hz, 1H, CH2 
Gly), 3.78 (d, J = 17.1 Hz, 2H, CH2 Gly, CH2δ Pro), 3.60 (m, 1H, CH2δ Pro), 3.30-3.13 (m, 6H, 
CH2β His), 2.28 (m, 1H, CH2β Pro), 2.09 (m, 1H, CH2β Pro), 1.97 (m, 2H, CH2γ Pro), 1.94 (s, 
3H, CH3 Ac);
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 175.5, 174.5, 173.6, 172.1, 171.7, 170.9, 135.14, 
135.12, 131.3, 131.1, 118.6, 118.5, 62.6, 53.6, 53.3, 43.8, 30.5, 28.0, 27.4, 26.3, 26.1, 22.5.
ESI-MS: 488.1 [M+H]+ (calcd.: 487.5).
Ac-His-Ahx-Asp-NHR (R=Tentagel (3a) and R=H (3b))
C18H28N6O6 424.21 g/mol
   
1H-NMR (400 MHz, D2O, 25 °C): δ (ppm) = 8.49 (s, 1H, CHImi), 7.16 (s, 1H, CHImi), 4.45 (m, 
2H, CHα His, CHα Asp), 3.04 (m, 4H, CH2β His, NHCH2 Ahx), 2.58 (dd, J = 5.01 Hz, 15.98 
Hz, 2H, CH2β Asp, CH2β Asp), 2.46 (dd, J = 8.76 Hz, 15.98 Hz, 2H, NHCH2 Ahx), 2.15 (t, J = 
7.18 Hz, 14.18 Hz, 2H, CH2CO Ahx), 1.86 (s, 3H, CH3 Ac), 1.43 (m, 2H, CH2 Ahx) 1.29 (m, 
2H, CH2 Ahx), 1.07 (m, 2H, CH2 Ahx)
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 177.3, 176.7, 174.4, 171.9, 133.9, 129.0, 117.5, 
53.3, 51.6, 39.5, 39.0, 35.6, 28.2, 26.9, 25.6, 25.0, 22.0
ESI-MS: 425.1 [M+H]+ (calcd.: 424.2).
Ac-His-Pro-Gly-Asp-NHR (R=Tentagel (3e) and R=H (3d))
C19H27N7O7 465.46 g/mol
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1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 8.79 (s, 1H, CHImi), 7.43 (s, 1H, CHImi), 4.97 (t, 
J = 6.8 Hz, 1H, CHα His), 4.80 (dd, J = 8.3 Hz, 5.6 Hz, 1H, CHα Asp), 4.35 (t, J = 7.1 Hz, 1H, 
CHα Pro), 4.05 (d, J = 16.6 Hz, 1H, CH2 Gly), 3.83 (m, 1H, CH2δ Pro), 3.77 (d, J = 16.6 Hz, 1H, 
CH2 Gly), 3.50 (m, 1H, CH2δ Pro), 3.20 (dd, J = 15.1 Hz, 6.8 Hz, 1H, CH2β His), 3.07 (dd, J = 
15.1 Hz, 6.8 Hz, 1H, CH2β His), 2.94 (dd, J = 16.9 Hz, 5.3 Hz, 1H, CH2β Asp), 2.83 (dd, J = 
16.7 Hz, 8.3 Hz, 1H, CH2β Asp), 2.25 (m, 1H, CH2β Pro), 2.08 (m, 1H, CH2β Pro), 1.97 (m, 5H, 
CH3 Ac, CH2γ Pro); 
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 175.7, 174.1, 173.1, 171.6, 170.9, 135.2, 130.4, 
119.1, 62.4, 51.7, 51.1, 43.9, 36.7, 30.7, 27.6, 26.3, 25.0, 22.3
ESI-MS: 466.1 [M+H]+ (calcd.: 465.5).
Ac-Ser-Ahx-Tyr-NHR (R=Tentagel (4a) and R=H (4b))
C20H30N4O6 422.48 g/mol
   
1H-NMR (400.0 MHz, D2O, 25 °C): δ (ppm) = 7.03 (d, J = 8.44 Hz, 2H, Tyr), 6.71 (d, J = 8.48 
Hz, 2H, Tyr), 4.43 (m, 1H, CHα, Tyr), 4.20 (t, J = 5.38 Hz, 10.72 Hz, 1H, CHα Ser), 3.69 (d, J = 
5.38 Hz, 2H, CH2β Ser), 3.01 (m, 4H, COCH2 Ahx), 2.70 (m, 2H, CH2β Tyr), 2.04 (m, 2H, CH3 
Ac), 1.24 (m, 4H, CH2 Ahx), 0.86 (m, 2H, CH2 Ahx)
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13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 177.3, 176.7, 174.8, 171.9, 154.7, 130.8, 128.9, 
115.8, 61.5, 56.3, 54.9, 39.5, 36.6, 35.7, 28.3, 25.2, 22.1
ESI-MS: 423.2 [M+H]+ (calcd.: 422.5).
Ac-Ser-ProGly-Tyr-NHR (R=Tentagel (4e) and R=H (4e))
C21H29N5O7  463.48 g/mol
   
1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 7.01 (d, J = 8.34 Hz, 2H, Tyr), 6.71 (d, J = 8.36 
Hz, 2H, Tyr), 4.60 (m, 1H, CHα Tyr), 4.40 (dd, J = 6.22 Hz, 8.37 Hz, 1H, CHα Ser), 4.30 (dd, J = 
5.88 Hz, 8.32 Hz, 1H, CHα Pro), 3.65 (m, 4H, CH2 Gly, CH2β Ser), 2.97 (dd, J = 6.10 Hz, 14.07 
Hz, 1H, CH2δ Pro), 2.82 (dd, J = 8.44 Hz, 14.13 Hz, 2H, CH2β Tyr), 2.13 (m, 1H, CH2β Pro), 
1.88 (m, 4H, CH3 Ac, CH2γ Pro), 1.74 (m, 2H, CH2γ Pro).
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 176.1, 175.1, 174.5, 171.4, 170.8, 154.8, 130.9, 
128.6, 115.8, 61.3, 60.9, 55.1, 54.1, 48.4, 42.6, 36.5, 29.6, 25.0, 21.9.
ESI-MS: 464.1 [M+H]+ (calcd.: 463.5).
Ac-His-ProAib-Ser-NH2 (5)
C20H31N7O6 465.50 g/mol
	
   	
   	
      
147
1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 8.80 (s, 1H, CH His), 7.39 (s, 1H, CH His), 4.67 
(m, 2H, CHα His), 4.28 (m, 2H, CHα Pro, CHα Ser), 3.83 (m, 2H, CH2β Ser, CH2δ Pro), 3.62 (m, 
1H, CH2δ Pro), 3.21 (dd, J = 15.1 Hz, 5.6 Hz, 1H, CH2β His), 3.06 (dd, J = 15.4 Hz, 8.2 Hz, 1H, 
CH2β His), 2.26 (m, 1H, CH2β Pro), 2.10 (m, 1H, CH2β Pro), 1.97 (m, 5H, CH3 Ac, CH2γ Pro), 
1.48 (s, CH3 Aib), 1.45 (s, CH3 Aib).
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 175.6, 174.7, 174.6, 173.1, 170.9, 134.9, 131.1, 
118.8, 62.9, 58.2, 57.9, 51.9, 36.4, 30.6, 27.8, 26.2, 25.6, 25.6, 25.4, 22.4.
ESI-MS: 466.3 [M+H]+ (calcd.: 465.5).
Ac-Asp-Ahx-Ser-NH2 (6)
C15H26N4O7 374.39 g/mol
   
1H-NMR (500.0 MHz, D2O, 25°C): 4.58 (t, J = 6.5 Hz, 1H, CHα Asp), 4.33 (t, J = 5.0 Hz, 1H, 
CHα Ser), 3.68 (m, 2H, CH2β Ser), 3.10 (t, J = 6.5 Hz, 1H, NHCH2 Ahx), 2.70 (dd, J = 16.5 Hz, 
7.5 Hz, 2H, CH2β Asp, CH2β Asp), 2.20 (m, 4H, NHCH2 Ahx, CH2CO Ahx), 1.90 (s, 3H, CH3 
Ac), 1.54 (m, 2H, CH2 Ahx), 1.44 (m, 2H, CH2 Ahx), 1.27 (m, 2H, CH2 Ahx).
13C-NMR (100.6 MHz, D20, 25°C): δ (ppm) = 176.2, 176.1, 174.8, 173.6, 169.0, 63.1, 56.5 51.5 
40.3, 37.0, 36.7, 29.9, 27.4, 26.3, 22.7.
ESI-MS: 375.2 [M+H]+ (calcd.: 374.4).
Ac-Ser-ProGly-D-His-NH (R=Tentagel (9a) and R=H (9b))
C18H27N7O6 437.45 g/mol
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1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 7.67 (s, 1H, CHImi), 6.95 (s, 1H, CHImi), 4.73 (t, 
J = 6.80 Hz, 2H, CHα His), 4.54 (m, 1H, CHα Ser), 4.40 (t, J = 7.0 Hz, 1H, CHα Pro), 3.83 (m, 
1H, CH2δ Pro, CH2 Gly), 3.78 (m, 4H, CH2 Gly, CH2β Ser), 3.74 (m, 2H, CH2δ Pro), 3.12 (dd, 
J = 14.5 Hz, 5.5 Hz, 1H, CH2β His), 3.07 (dd, J = 15.0 Hz, 9.5 Hz, 1H, CH2β His), 2.27 (m, 1H, 
CH2β Pro), 2.01 (m, 1H, CH2β Pro), 1.95 (s, 3H, CH3 Ac), 1.88(m, 2H, CH2γ Pro).
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 175.6, 174.9, 174.1, 171.2, 170.5, 136.0, 61.0, 
60.4, 53.7, 53.5, 53.0,  48.0, 42.4, 31.5, 28.6, 24.6, 21.4.
ESI-MS: 438.3 [M+H]+ (calcd.: 437.5).
Ac-D-Lys-Pro-Trp-NHR (R=Tentagel (7a) and R=H (7b))
C24H34N6O4 470.56 g/mol
   
1H-NMR (400.0 MHz, D2O, 25°C): δ (ppm) = 7.65 (d, J = 7.5 Hz, 1H, CH Trp), 7.40 (d, J = 7.5 
Hz, 1H, CH Trp), 7.26 (s, 1H, CH Trp), 7.08 (m, 2H, Trp), 4.65 (m, 1H, CHα Trp), 4.16 (m, 2H, 
CHα Lys, CHα Pro), 3.40 (m, 4H, CH2δ Pro, CH2β Trp), 2.66 (t, J = 7.5 Hz, 2H, CH2 Lys), 2.26 
(m, 1H, CH2δ Pro), 1.96 (m, 4H, CH2β Pro, CH3 Ac), 1.83 (m, 2H, CH2γ Pro), 1.24 (m, 5H, 
CH2 Lys).
13C-NMR (100.6 MHz, D2O, 25°C): δ (ppm) = 176.1, 174.1, 173.8, 173.7, 173.3, 136.1, 126.9, 
121.8, 119.2, 118.2, 111.72, 109.7, 61.1, 55.2, 53.8, 52.3, 47.7, 39.7, 39.5, 29.5, 29.3, 28.6, 26.3, 
23.5, 22.0, 21.4, 21.2.
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ESI-MS: 471.3 [M+H]+ (calcd.: 470.6).
Ac-D-Trp-D-Phe-D-Ser-NHR (R=Tentagel (10a) and R=H (10b))
C25H29N5O5 479.53 g/mol
   
1H-NMR (400.0 MHz, CD3OD, 25°C): δ (ppm) = 7.55 (d, J = 9.0 Hz, 1H, CH Trp), 7.40 (d, J = 
8.5 Hz, 1H, CH Trp), 7.14 (t, J = 7.5 Hz, 2H, CH Trp, CH Phe), 4.59 (m, 4H, CHα Trp, CHα 
Phe), 4.34 (m, 1H, CHα Ser), 3.90 (t, J = 6.5 Hz, 2H, CH2β Ser), 3.03 (m, 4H, CH2β Phe, Trp ), 
1.89 (m, 3H, CH3 Ac).
13C-NMR (100.6 MHz, CD3OD, 25°C): δ (ppm) = 176.1, 174.1, 173.8, 173.7, 173.3, 
136.1,138.3, 138.1, 129.6, 128.8. 127.9, 122.5, 119.9, 119.3, 112.3, 110.8, 63.0, 56.8, 56.0, 38.1, 
28.5,  22.5.
ESI-MS: 480.3 [M+H]+ (calcd.: 479.5).
11.8 Ag-Nanoparticle Formation by Solid Supported Peptides
In the formation of AgNPs, peptides bound on Tentagel resin were treated under the same 
conditions as for the screening of the libraries. Images were taken using a light microscope and 
the formation of AgNPs on bead was confirmed by SEM studies.
11.9 Ag+ Uptake Studies of Solid Supported Peptides
Sample preparation: 10.0 mg of dry resin (exact weight) were suspended in a solution of AgNO3 
(0.05 M, 660 µL) solution and sonicated for 15 min. Then, 500 µL of the solution was removed 
and diluted to 50 mL. 5 mL of the solution obtained was diluted again to 100 mL after addition of 
2 mL of 10% HNO3. Then the Ag concentration of this solution was measured by  atom 
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absorption spectroscopy (AAS) measurements and compared with the concentration of the 
reference solution prepared from the starting AgNO3 solution (0.05 M) diluted in the same way.
Peptide Bead colour AgNP size mM Ag/mM peptide
2a Dark red 50-200 nm 0.38
2b Dark red 50-200 nm 0.64
3a Dark orange 50-200 nm 0.55
3c Dark orange 50-200 nm 0.47
4a Yellow ≤10 nm 0.26
4b Yellow ≤10 nm 0.19
Table 14: Ag+-ion uptake by peptides bound on Tentagel resin
11.10	
  Solution Phase Experiments of AgNP Formation in the Presence of Peptides
An aqueous solution of AgNO3 was added to an aqueous solution of peptide (already adjusted to 
the required pH by using either NaOH (2 M) or HNO3 (2 M)) followed by incubating the reaction 
mixture for 15 minutes. Vitamin C was then added to reduce Ag+ to Ag0. UV-Vis spectroscopy 
was used as an initial confirmation for the formation of AgNPs whose sizes were then determined 
by TEM analyses.
11.11	
  Synthesis of Library 1
  
Figure 103: General structure of peptide library 18
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Prior to library  synthesis, reaction vessels were silylated using TMSCl (10% (v/v)) in anhydrous 
toluene to reduce the tendency  of the resin beads to stick to the glass surfaces. This was achieved 
through overnight agitation of reaction vessels containing the silylating mixture. Before use, the 
reaction vessels were washed with CH2Cl2 (5x) and dried at 110 oC overnight.
Splitting and encoding: Prior to the coupling of Fmoc amino acids, poly  halo tags encoding each 
amino acid residue are coupled, allowing each peptide immobilised on an individual bead to be 
unoquivocally  identified after library screening. Amino-functionalized Tentagel resin (2.1 g, 0.92 
mmol, loading 0.44 mmol/g) was split into seven equal portions of 300 mg (0.13 mmol) each and 
placed into fifteen 25 mL Merrifield shaking vessels. Each portion was then suspended in dry 
CH2Cl2 (5 mL). The relevant tags (2 mol% total resin loading) encoding each amino acid in the 
library and HOBt (1.0 eq) were dissolved in the smallest amount of DMF possible and added to 
the resin in the reaction vessels. The mixtures were shaken for at least 5 min to ensure an equal 
distribution of the tags. This was followed by the addition of DIC (20 µL, 0.20 mmol, 1.5 eq. per 
tag) to each reaction vessel and the mixture was shaken immediately  and allowed to continue 
shaking overnight (nominally 12 hours). The fifteen portions of resin were then washed with 
DMF (3x) and with CH2Cl2 (3x).
Decoding of tags: In order to check the efficiency of each coupling, 5 beads from each reaction 
vessel were isolated and analysed. Sampled beads were transferred to microscope slides and 
swollen in GC quality DMF. Single beads were chosen at  random and each transferred by 
Eppendorf (10 µL micro tips) to the open mouth of a 20 µL capillary tube (previously flame-
melted at one end and cut to a length of 4.5 cm). Capillaries were centrifuged (10,000 rpm for 30 
seconds) to move the bead to the closed end of the capillary, and were subsequently washed with 
GC quality  DMF (5x) with an analytical syringe (10 µL) to remove debris or traces of coupling 
reagents from the bead. A final quantity of GC quality DMF (2.5 µL) was added to each capillary 
in preparation for tag cleavage. Capillaries were then closed at the open end and irradiated for 2 h 
under high intensity UV light thereby liberating the tag alcohols contained on each bead into the 
supernatant DMF. Tag alcohol solutions were silylated in situ by addition of BSA (1 µL) and 
analysed by GC-ECD (temperature gradient: 200-320 ºC in 11 min). In cases where insufficient 
trace intensity was produced, the tag coupling protocol was repeated.
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Coupling of the Amino Acids: Amino acid couplings and the Fmoc-deprotections were performed 
as described in the general protocol. After tag coupling was confirmed to be successful, the 
processes of splitting, encoding of the resin and coupling of each amino acid cycles were 
repeated using the protocols described above until the tripeptides were assembled (Figure 104 
and Table 14). Finally, the N-termini were acetylated following the general protocol for 
acetylation.
Figure 104: Tags and amount used for each encoding step
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Table 14: Scheme of encoding library 1
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11.12 Synthesis of Library 2
During the synthesis of library  2, the same procedures as for library 1 were used. Library 2 was 
synthesised on a larger scale of amino-functionalised resin (1.0 eq Tentagel S NH2, 10 g, 0.3 
mmol/g, 3.00 mmol). In addition 3 mol% of the relevant tags encoding each amino acid in the 
library was used instead of 2 mol% used for library 1. Furthermore a larger variety  of amino 
acids were used for the synthesis of library 2 (Table 15) as well as other tags (Figure 105).
Step 1: (CH2)9-Cl5 (631.71 g/mol), 6 µmol, 3.8 mg = tag Nr. 1 (T1) 
 (CH2)10-Cl5 (645.74 g/mol), 6 µmol, 3.9 mg = tag Nr. 1 (T2) 
 (CH2)11-Cl5 (659.77 g/mol), 6 µmol, 4.0 mg = tag Nr. 1 (T3) 
 (CH2)12-Cl5 (673.79 g/mol), 6 µmol, 4.0 mg = tag Nr. 1 (T4)
Step 2: (CH2)11-(2,4,6)-Cl3 (590.9 g/mol), 6 µmol, 3.5 mg, = tag Nr. 1 (T5) 
 (CH2)11-(2,4,5)-Cl3 (590.9 g/mol), 6 µmol, 3.5 mg, = tag Nr. 1 (T6) 
 (CH2)12-(2,4,6)-Cl3 (604.9 g/mol), 6 µmol, 3.6 mg, = tag Nr. 1 (T7) 
 (CH2)12-(2,4,5)-Cl3 (604.9 g/mol), 6 µmol, 3.6 mg, = tag Nr. 1 (T8)
Step 3: (CH2)7-(2,4,6)-Cl3 (534.8 g/mol), 6 µmol, 3.2 mg, = tag Nr. 1 (T9) 
 (CH2)7-(2,4,5)-Cl3 (534.8 g/mol), 6 µmol, 3.2 mg, = tag Nr. 1 (T10)
 (CH2)8-(2,4,6)-Cl3 (548.8 g/mol), 6 µmol, 3.3 mg, = tag Nr. 1 (T11)
 (CH2)8-(2,4,5)-Cl3 (548.8 g/mol), 6 µmol, 3.3 mg, = tag Nr. 1 (T12)
Figure 105: Tags and amount used for each encoding step
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 Step 1        M (g/mol)   m (mg)            Tag              Code
                      T1   T2    T3  T4
Fmoc-L-Pro-OH 337.38 223 T1 1   0   0   0
Fmoc-D-Arg(Pbf)-OH 648.78 428 T2 0   1   0   0
Fmoc-L-Lys(Boc)-OH 468.55 309 T3 0   0   1   0
Fmoc-D-His(Trt)-OH 619.72 409 T4 0   0   0   1
Fmoc-L-Trp(Boc)-OH 526.59 348 T1 + T2 1   1   0   0
Fmoc-D-Asp(OtBu)-OH 411.46 272 T1 + T3 1   0   1   0
Fmoc-L-Glu(OtBu)-OH 443.50 293 T1 + T4 1   0   0   1
Fmoc-D-Asn(Trt)-OH 596.68 394 T2 + T3 0   1   1   0
Fmoc-L-Gln(Trt)-OH 610.71 403 T2 + T4 0   1   0   1
Fmoc-D-Ser(tBu)-OH 383.44 253 T3 + T4 0   0   1   1
Fmoc-L-Thr(tBu)-OH 397.47 262 T1 + T2 + T3 1   1   1   0
Fmoc-D-Tyr(tBu)-OH 459.54 303 T1 + T2 + T4 1   1   0   1
Fmoc-L-Phe-OH 387.44 256 T1 + T3 + T4 1   0   1   1
Fmoc-D-Val-OH 339.39 224 T2 + T3 + T4 0   1   1   1
Fmoc-L-Ala-OH.H2O 329.35 217 T1 + T2 + T3 + T4 1   1   1   1
   Step 2                M (g/mol)   m (mg)              Tag              Code
                      T1  T2 T3 T4
Fmoc-L-Pro-OH                   337.38 222            T5            1   0   0   0
1) Fmoc-Aib-OH (Pro-Aib)         325.36 215            T6             0   1   0   0
2) Fmoc-L-Pro-OH          337.38 223           
Fmoc-Ahx           353.42 234           T7                           0   0   1   0
1) Fmoc-Gly-OH (Pro-Gly)          297.31 196           T8                     0   0   0   1
2) Fmoc-L-Pro-OH          337.36 222   
(1R,2R)-Fmoc-Achc-OH                  365.43 241           T5 + T6                          1   1   0   0
(1S,2S)-Fmoc-Achc-OH 365.43 241 T5 + T7 1   0   1   0
Fmoc-Cl (no motif) 258.7 171 T5 + T8 1   0   0   1
Fmoc-Gly-OH 297.31 196 T6 + T7 0   1   1   0
Fmoc-L-Leu-OH 353.42 233 T6 + T8 0   1   0   1
Fmoc-D-Leu-OH 353.42 233 T7 + T8 0   0   1   1
Fmoc-D-Phe-OH 387.44 256 T5 + T6 + T7 1   1   1   0
Fmoc-L-Phe-OH 387.44 256 T5 + T6 + T8 1   1   0   1
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Fmoc-D-Val-OH 339.39 224 T5 + T7 + T8 1   0   1   1
Fmoc-L-Val-OH 339.39 224 T6 + T7 + T8  0   1   1  1
Fmoc-L-Ala-OH.H2O          329.35 217          T5 + T6 + T7 + T8                   1   1   1  1
Step 3                M (g/mol)   m (mg)             Tag   Code
                        T1  T2 T3 T4
Fmoc-D-Pro-OH 337.38 223 T9                                         1   0   0   0
Fmoc-L-Arg(Pbf)-OH 648.78 428 T10                                        0   1   0   0
Fmoc-D-Lys(Boc)-OH 468.55 309 T11                                         0   0   1   0
Fmoc-L-His(Trt)-OH 619.72 409 T12                                         0   0   0   1
Fmoc-D-Trp(Boc)-OH 526.59 347 T9 + T10                                 1   1   0   0
Fmoc-L-Asp(OtBu)-OH 411.46 272 T9 + T11                                 1   0   1   0
Fmoc-D-Glu(OtBu)-OH 425.48 281 T9 + T12                                 1   0   0   1
Fmoc-L-Asn(Trt)-OH 596.68 394 T10 + T11                                0   1   1   0
Fmoc-D-Gln(Trt)-OH 610.71 403 T10 + T12                                0   1   0   1
Fmoc-L-Ser(tBu)-OH 383.44 253 T11 + T12                                0   0   1   1
Fmoc-D-Thr(tBu)-OH 397.47 262 T9 + T10 + T11                        1   1   1   0
Fmoc-L-Tyr(tBu)-OH 459.54 303 T9 + T10 + T12                        1   1   0   1
Fmoc-D-Phe-OH 387.44 256 T9 + T11 + T12                        1   0   1   1
Fmoc-L-Val-OH 339.39 224 T10 + T11 + T12                       0   1   1   1
Fmoc-D-Ala-OH.H2O 329.35 217 T9 + T10 + T11 + T12               1   1   1   1
Table 15: Scheme of encoding library 2
11.13 Combinatorial Screening Experiments (AgNPs)
Approximately  10 mg of the library  were suspended in a solution of AgNO3 (0.05 M, 660 µL), 
sonicated for 5 min and allowed to incubate for another 10 min. After washing with nanopure 
water (10 x 1 mL), the beads were incubated with a solution of sodium ascorbate (0.05 M, 660 
µL, ~6 eq.) for 10 min before washing with nanopure water (10 x 1 mL ).
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Table 16: Consensus peptide sequences of library 1 on differently coloured beads
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The combinatorial screening assays were evaluated using a light microscope, a sample of beads 
from each colour category were isolated and the peptide sequences analyzed by EC-GC.
11.14 Combinatorial Screening Experiments (PtNPs)
Approximately  10 mg of library-beads were suspended in an aqueous solution of K2PtCl4 (0.05 
M, 660 µL), sonicated and allowed to incubate for 15 min. After washing with deionized water 
(10 x 1 mL), the beads were incubated with a solution of sodium borohydride (0.4 M, 660 μL) 
for 6 h before washing with deionized water (10 x 1 mL). The combinatorial screening assay was 
evaluated using a light microscope, a sample of beads from each colour category were isolated 
and the peptide sequences analyzed by EC-GC.
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XII.
ABBREVIATIONS
AcOH  Acetic acid
Ag  Silver
Ahx  6-Aminohexanoic acid
Aib  Aminoisobutyric acid
Alloc  Allyloxycarbonyl
Boc  tert-Butyloxycarbonyl
BSA  N,O-Bistrimethylsilylacetamide
CDCl3  Deuterated Chloroform
CH2Cl2 Dichloromethane
d  Doublet
δ Chemical shift (ppm) 
DCC  N,N’-Dicyclohexylcarbodiimide
DIC  N,N’-Diisopropylcarbodiimide  
DMF   N,N-Dimethylformamide
DMSO  Dimethylsulfoxide
ESIMS  Electrospray Ionisation Mass Spectrometry
eq  Equivalents
Et3N  Triethylamine
Et2O  Diethyl Ether
Fmoc  9-Fluorenylmethoxycarbonyl
GC  Gas Chromatography
HCTU 2-(6-Chloro-1-H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium 
hexafluorophosphate
HOBt  1-Hydroxybenzotriazole
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i-Pr2NEt N,N-Diisopropylethylamine
i-Pr  Isopropyl
J  Scalar coupling constant (Hz)
λ  Wavelength (nm)
m  Multiplet
MeOH Methanol
MHz  Megahertz
m/z  Mass to Charge Ratio
NMM  N-Methylmorpholine
NMR  Nuclear Magnetic Resonance
NP  Nanoparticle
PEG  Poly(ethylene) glycol
RT  Room temperature
s  Singlet (NMR)
tBu  tert-Butyl
TFA  2,2,2-Trifluoroacetic acid
TIS   Triisopropylsilane
TNBS   2,4,6-Trinitrobenzenesulfonic acid
Trt  Trityl (Triphenylmethyl-)
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